Clinical Trials

Amlodipine besylate has been evaluated across numerous Phase 1 through Phase 4 clinical trials, primarily targeting hypertension, hypertension with hyperlipidemia, atrial fibrillation, and diabetic proteinuria. Funded by academic institutions, medical centers, and industry sponsors including Takeda and Midas Pharma GmbH, these global studies reflect completed, active, recruiting, and terminated statuses. Furthermore, late-stage trials have assessed fixed-dose amlodipine combinations to manage concurrent hypertension and hyperlipidemia, as well as to improve left atrial mechanical function in patients with atrial fibrillation.

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07075965 NOT_YET_RECRUITING
Myotonic Dystrophy 1
University of Rochester
 2026-12-07 PHASE1
NCT07075965 NOT_YET_RECRUITING
Myotonic Dystrophy 1
University of Rochester
 2026-12-07 PHASE1
NCT04974138 RECRUITING
Hypertension; MTHFR 677 CC or CT Genotype; Elevated Plasma Homocysteine (Hcy≥10µmol/L); Insufficient Plasma Folate Levels (<12ng/mL)
Shenzhen Ausa Pharmed Co.,Ltd
 2024-08-22 PHASE4
NCT04974138 RECRUITING
Hypertension; MTHFR 677 CC or CT Genotype; Elevated Plasma Homocysteine (Hcy≥10µmol/L); Insufficient Plasma Folate Levels (<12ng/mL)
Shenzhen Ausa Pharmed Co.,Ltd
 2024-08-22 PHASE4
NCT05155137 RECRUITING
Stroke; Cognitive Decline
Hospital Moinhos de Vento
 2021-12-20 PHASE3
NCT05155137 RECRUITING
Stroke; Cognitive Decline
Hospital Moinhos de Vento
 2021-12-20 PHASE3
NCT07458880 RECRUITING
Intracerebral Hemorrhage
The University of Hong Kong
 2026-03-01
NCT07458880 RECRUITING
Intracerebral Hemorrhage
The University of Hong Kong
 2026-03-01
NCT04974151 RECRUITING
Hypertension; MTHFR 677 TT Genotype
Shenzhen Ausa Pharmed Co.,Ltd
 2024-08-22 PHASE4
NCT04974151 RECRUITING
Hypertension; MTHFR 677 TT Genotype
Shenzhen Ausa Pharmed Co.,Ltd
 2024-08-22 PHASE4
NCT06780865 NOT_YET_RECRUITING
Chronic Kidney Disease(CKD); Nocturnal Hypertension
Shanghai Institute of Hypertension
 2025-01-30
NCT06780865 NOT_YET_RECRUITING
Chronic Kidney Disease(CKD); Nocturnal Hypertension
Shanghai Institute of Hypertension
 2025-01-30
NCT06730945 WITHDRAWN
Coronary Artery Bypass Graft Surgery (CABG); Radial Artery Grafts; Graft Failure
Ruijin Hospital
 2025-06 PHASE4
NCT06730945 WITHDRAWN
Coronary Artery Bypass Graft Surgery (CABG); Radial Artery Grafts; Graft Failure
Ruijin Hospital
 2025-06 PHASE4
NCT06150560 ENROLLING_BY_INVITATION
Coarctation of Aorta; High Blood Pressure
Mayo Clinic
 2024-04-01 PHASE3
NCT06150560 ENROLLING_BY_INVITATION
Coarctation of Aorta; High Blood Pressure
Mayo Clinic
 2024-04-01 PHASE3
NCT05331144 ACTIVE_NOT_RECRUITING
Cognitively Normal Older Adults; Hypertension; Subjective Cognitive Decline; Family History of Dementia
Rong Zhang
 2022-10-25 PHASE2
NCT05331144 ACTIVE_NOT_RECRUITING
Cognitively Normal Older Adults; Hypertension; Subjective Cognitive Decline; Family History of Dementia
Rong Zhang
 2022-10-25 PHASE2
NCT07687160 NOT_YET_RECRUITING
Hypertension
Ottawa Hospital Research Institute
 2026-09-01 PHASE4
NCT07687160 NOT_YET_RECRUITING
Hypertension
Ottawa Hospital Research Institute
 2026-09-01 PHASE4
NCT07618806 NOT_YET_RECRUITING
Hypertension; Oedema
Zentiva, k.s.
 2026-11-30 PHASE3
NCT07618806 NOT_YET_RECRUITING
Hypertension; Oedema
Zentiva, k.s.
 2026-11-30 PHASE3
NCT06942377 NOT_YET_RECRUITING
Endometrial Cancer
Peking University People's Hospital
 2025-07-15 PHASE2
NCT06942377 NOT_YET_RECRUITING
Endometrial Cancer
Peking University People's Hospital
 2025-07-15 PHASE2
NCT07259733 RECRUITING
Apparent Resistant Hypertension; Hypertension; High Blood Pressure
Instituto Dante Pazzanese de Cardiologia
 2023-07-15
NCT07259733 RECRUITING
Apparent Resistant Hypertension; Hypertension; High Blood Pressure
Instituto Dante Pazzanese de Cardiologia
 2023-07-15
NCT06424834 RECRUITING
Angina Pectoris; Microvascular Angina; Vasospastic Angina; Myocardial Bridge of Coronary Artery
Stanford University
 2024-10-10 PHASE2; PHASE3
NCT06424834 RECRUITING
Angina Pectoris; Microvascular Angina; Vasospastic Angina; Myocardial Bridge of Coronary Artery
Stanford University
 2024-10-10 PHASE2; PHASE3
NCT05416840 NOT_YET_RECRUITING
Hypertension
Jing Liu
 2024-01 PHASE4
NCT05416840 NOT_YET_RECRUITING
Hypertension
Jing Liu
 2024-01 PHASE4
NCT04111419 ACTIVE_NOT_RECRUITING
Atrial Fibrillation; Hypertension
Shanghai Jiao Tong University School of Medicine
 2020-07-01 PHASE4
NCT04111419 ACTIVE_NOT_RECRUITING
Atrial Fibrillation; Hypertension
Shanghai Jiao Tong University School of Medicine
 2020-07-01 PHASE4
NCT04978649 WITHDRAWN
Diabetes Mellitus, Type 2; Blood Pressure
Guangdong Provincial People's Hospital
 2021-09-01 PHASE4
NCT04978649 WITHDRAWN
Diabetes Mellitus, Type 2; Blood Pressure
Guangdong Provincial People's Hospital
 2021-09-01 PHASE4
NCT07683585 RECRUITING
Hypertension; Coronary Arterial Disease; Percutaneous Coronary Intervention
National Medical Research Center for Therapy and Preventive Medicine
 2026-04-01
NCT07683585 RECRUITING
Hypertension; Coronary Arterial Disease; Percutaneous Coronary Intervention
National Medical Research Center for Therapy and Preventive Medicine
 2026-04-01
NCT05089448 RECRUITING
Hypertension; Blood Pressure; Drug Use
Yan Li
 2021-01-28 PHASE4
NCT05089448 RECRUITING
Hypertension; Blood Pressure; Drug Use
Yan Li
 2021-01-28 PHASE4
NCT07291375 NOT_YET_RECRUITING
Contrast-induced Nephropathy
Minia University
 2025-12-20 EARLY_PHASE1
NCT07291375 NOT_YET_RECRUITING
Contrast-induced Nephropathy
Minia University
 2025-12-20 EARLY_PHASE1
NCT04121299 WITHDRAWN
Masked Hypertension
University of Alabama at Birmingham
 2021-07 PHASE3
NCT04121299 WITHDRAWN
Masked Hypertension
University of Alabama at Birmingham
 2021-07 PHASE3
NCT07486453 NOT_YET_RECRUITING
Primary Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd.
 2026-03-09 PHASE1
NCT07486453 NOT_YET_RECRUITING
Primary Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd.
 2026-03-09 PHASE1
NCT06771245 NOT_YET_RECRUITING
Mild-to-moderate Essential Hypertension
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
 2025-01-24 PHASE3
NCT06771245 NOT_YET_RECRUITING
Mild-to-moderate Essential Hypertension
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
 2025-01-24 PHASE3
NCT06041529 ACTIVE_NOT_RECRUITING
Essential Hypertension
Yuhan Corporation
 2023-10-18 PHASE4
NCT06041529 ACTIVE_NOT_RECRUITING
Essential Hypertension
Yuhan Corporation
 2023-10-18 PHASE4
NCT05370599 TERMINATED
Hypertension
University of California, San Francisco
 2022-04-15 PHASE2
NCT05370599 TERMINATED
Hypertension
University of California, San Francisco
 2022-04-15 PHASE2
NCT06523465 RECRUITING
Primary Aldosteronism; Statin; Mineralocorticoid Receptor Antagonist; Hypertension
Third Military Medical University
 2024-09-10 PHASE4
NCT06523465 RECRUITING
Primary Aldosteronism; Statin; Mineralocorticoid Receptor Antagonist; Hypertension
Third Military Medical University
 2024-09-10 PHASE4
NCT07704697 COMPLETED
Essential Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd.
 2024-11-23 PHASE3
NCT07704697 COMPLETED
Essential Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd.
 2024-11-23 PHASE3
NCT05917275 UNKNOWN
Primary Hypertension
Radboud University Medical Center
 2024-04-04 PHASE4
NCT05917275 UNKNOWN
Primary Hypertension
Radboud University Medical Center
 2024-04-04 PHASE4
NCT04840342 ACTIVE_NOT_RECRUITING
Hypertension; Mineralocorticoid Excess
Brigham and Women's Hospital
 2022-02-03 PHASE4
NCT04840342 ACTIVE_NOT_RECRUITING
Hypertension; Mineralocorticoid Excess
Brigham and Women's Hospital
 2022-02-03 PHASE4
NCT03264352 RECRUITING
Diabetes Mellitus, Type 2; Adverse Event; Blood Pressure; Prehypertension; Cardiovascular Risk Factor
XueQing Yu
 2018-02-01 PHASE4
NCT03264352 RECRUITING
Diabetes Mellitus, Type 2; Adverse Event; Blood Pressure; Prehypertension; Cardiovascular Risk Factor
XueQing Yu
 2018-02-01 PHASE4
NCT02699645 COMPLETED
Intracerebral Haemorrhage (ICH); Hypertension
The George Institute
 2017-09-28 PHASE3
NCT02699645 COMPLETED
Intracerebral Haemorrhage (ICH); Hypertension
The George Institute
 2017-09-28 PHASE3
NCT07704684 COMPLETED
Essential Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd.
 2023-06-28 PHASE3
NCT07704684 COMPLETED
Essential Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd.
 2023-06-28 PHASE3
NCT06236061 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2024-04-08 PHASE3
NCT06236061 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2024-04-08 PHASE3
NCT06646354 ENROLLING_BY_INVITATION
Hypertension; Primary Hypercholesterolaemia
Hyundai Pharm
 2025-04-22 PHASE3
NCT06646354 ENROLLING_BY_INVITATION
Hypertension; Primary Hypercholesterolaemia
Hyundai Pharm
 2025-04-22 PHASE3
NCT05920005 COMPLETED
Hypertension
Hospital Israelita Albert Einstein
 2023-08-22 PHASE3
NCT05920005 COMPLETED
Hypertension
Hospital Israelita Albert Einstein
 2023-08-22 PHASE3
NCT05165251 UNKNOWN
Isolated Systolic Hypertension
Shanghai Jiao Tong University School of Medicine
 2022-01-04 PHASE4
NCT05165251 UNKNOWN
Isolated Systolic Hypertension
Shanghai Jiao Tong University School of Medicine
 2022-01-04 PHASE4
NCT04434664 COMPLETED
Heart Failure With Preserved Ejection Fraction; Hypertension
University of Pennsylvania
 2021-12-01 PHASE4
NCT04434664 COMPLETED
Heart Failure With Preserved Ejection Fraction; Hypertension
University of Pennsylvania
 2021-12-01 PHASE4
NCT07327749 COMPLETED
Hypertension
Shiraz University of Medical Sciences
 2022-10-01 PHASE4
NCT07327749 COMPLETED
Hypertension
Shiraz University of Medical Sciences
 2022-10-01 PHASE4
NCT05976438 UNKNOWN
Hypertension
Cambridge University Hospitals NHS Foundation Trust
 2023-08
NCT05976438 UNKNOWN
Hypertension
Cambridge University Hospitals NHS Foundation Trust
 2023-08
NCT03946514 COMPLETED
Hypertension
Shanghai Jiao Tong University School of Medicine
 2018-09-01 PHASE4
NCT03946514 COMPLETED
Hypertension
Shanghai Jiao Tong University School of Medicine
 2018-09-01 PHASE4
NCT05683301 COMPLETED
Primary Hypertension
Centre for Chronic Disease Control, India
 2022-08-30 PHASE4
NCT05683301 COMPLETED
Primary Hypertension
Centre for Chronic Disease Control, India
 2022-08-30 PHASE4
NCT06193044 UNKNOWN
Healthy Volunteer
International Bio service
 2024-05-07 PHASE1
NCT06193044 UNKNOWN
Healthy Volunteer
International Bio service
 2024-05-07 PHASE1
NCT04474899 UNKNOWN
Obesity; Hypertension
Royal Perth Hospital
 2015-06-24 PHASE4
NCT04474899 UNKNOWN
Obesity; Hypertension
Royal Perth Hospital
 2015-06-24 PHASE4
NCT07564726 COMPLETED
Hypertension; Hypercholesterolemia
Celltrion Pharm, Inc.
 2022-08-05 PHASE3
NCT07564726 COMPLETED
Hypertension; Hypercholesterolemia
Celltrion Pharm, Inc.
 2022-08-05 PHASE3
NCT04455178 UNKNOWN
Hypertension
Shanghai Jiao Tong University School of Medicine
 2020-09-23 PHASE4
NCT04455178 UNKNOWN
Hypertension
Shanghai Jiao Tong University School of Medicine
 2020-09-23 PHASE4
NCT05103332 COMPLETED
Hypertension
Alnylam Pharmaceuticals
 2021-11-05 PHASE2
NCT05103332 COMPLETED
Hypertension
Alnylam Pharmaceuticals
 2021-11-05 PHASE2
NCT05212597 UNKNOWN
Aortic Valve Insufficiency
Samsung Medical Center
 2022-01-12 PHASE2
NCT05212597 UNKNOWN
Aortic Valve Insufficiency
Samsung Medical Center
 2022-01-12 PHASE2
NCT04954196 WITHDRAWN
Frozen Embryo Transfer
University Hospital, Montpellier
 2021-10-08 PHASE2
NCT04954196 WITHDRAWN
Frozen Embryo Transfer
University Hospital, Montpellier
 2021-10-08 PHASE2
NCT05275907 WITHDRAWN
High Blood Pressure; Liver Transplant; Renal Function Abnormal
Northwestern University
 2022-07-12 PHASE4
NCT05275907 WITHDRAWN
High Blood Pressure; Liver Transplant; Renal Function Abnormal
Northwestern University
 2022-07-12 PHASE4
NCT02847338 COMPLETED
Hypertension
Cambridge University Hospitals NHS Foundation Trust
 2016-11 PHASE4
NCT02847338 COMPLETED
Hypertension
Cambridge University Hospitals NHS Foundation Trust
 2016-11 PHASE4
NCT04518306 COMPLETED
Hypertension
George Medicines PTY Limited
 2021-06-14 PHASE3
NCT04518306 COMPLETED
Hypertension
George Medicines PTY Limited
 2021-06-14 PHASE3
NCT03860220 COMPLETED
Hypertension; Dyslipidemias
Hyo-Soo Kim
 2019-04-25 PHASE4
NCT03860220 COMPLETED
Hypertension; Dyslipidemias
Hyo-Soo Kim
 2019-04-25 PHASE4
NCT03683069 COMPLETED
Hypertension; Genetics Hypertension
Brigham and Women's Hospital
 2019-01-15 PHASE4
NCT03683069 COMPLETED
Hypertension; Genetics Hypertension
Brigham and Women's Hospital
 2019-01-15 PHASE4
NCT05940909 UNKNOWN
Bioequivalence
Pharmtechnology LLC
 2023-06-24 PHASE1
NCT05940909 UNKNOWN
Bioequivalence
Pharmtechnology LLC
 2023-06-24 PHASE1
NCT04518293 COMPLETED
Hypertension
George Medicines PTY Limited
 2021-07-09 PHASE3
NCT04518293 COMPLETED
Hypertension
George Medicines PTY Limited
 2021-07-09 PHASE3
NCT05398393 UNKNOWN
Hepatitis B, Chronic; Lipid Disorder
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
 2022-01-01
NCT05398393 UNKNOWN
Hepatitis B, Chronic; Lipid Disorder
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
 2022-01-01
NCT04692467 COMPLETED
HIV/AIDS; Pre Hypertension
Weill Medical College of Cornell University
 2021-02-26 PHASE2
NCT04692467 COMPLETED
HIV/AIDS; Pre Hypertension
Weill Medical College of Cornell University
 2021-02-26 PHASE2
NCT04929600 UNKNOWN
Hypertension; Left Ventricular Hypertrophy
Shanghai Jiao Tong University School of Medicine
 2021-11-28 PHASE4
NCT04929600 UNKNOWN
Hypertension; Left Ventricular Hypertrophy
Shanghai Jiao Tong University School of Medicine
 2021-11-28 PHASE4
NCT05808725 COMPLETED
Hypertension; Coronary Artery Disease
Brillian Pharma Inc.
 2022-12-29 PHASE1
NCT05808725 COMPLETED
Hypertension; Coronary Artery Disease
Brillian Pharma Inc.
 2022-12-29 PHASE1
NCT05476354 COMPLETED
Essential Hypertension
Handok Inc.
 2022-07-05 PHASE3
NCT05476354 COMPLETED
Essential Hypertension
Handok Inc.
 2022-07-05 PHASE3
NCT05155436 COMPLETED
Hypertension; Potassium Imbalance
National Heart Foundation of Bangladesh
 2022-01-15 PHASE4
NCT05155436 COMPLETED
Hypertension; Potassium Imbalance
National Heart Foundation of Bangladesh
 2022-01-15 PHASE4
NCT05475665 COMPLETED
Essential Hypertension
Handok Inc.
 2022-07-14 PHASE3
NCT05475665 COMPLETED
Essential Hypertension
Handok Inc.
 2022-07-14 PHASE3
NCT05667818 UNKNOWN
Hypertension
Overseas Pharmaceuticals, Ltd.
 2023-01-28 PHASE1
NCT05667818 UNKNOWN
Hypertension
Overseas Pharmaceuticals, Ltd.
 2023-01-28 PHASE1
NCT05679102 COMPLETED
Atorvastatin Antihypertensive Effect
Himayat Ullah
 2022-12-20
NCT05679102 COMPLETED
Atorvastatin Antihypertensive Effect
Himayat Ullah
 2022-12-20
NCT05173025 UNKNOWN
Hypertension; Atherosclerosis; Diabetes Mellitus, Type 2; Renin Hypertension
Seoul National University Bundang Hospital
 2018-01-01 PHASE4
NCT05173025 UNKNOWN
Hypertension; Atherosclerosis; Diabetes Mellitus, Type 2; Renin Hypertension
Seoul National University Bundang Hospital
 2018-01-01 PHASE4
NCT05688085 COMPLETED
Healthy Volunteers
Handok Inc.
 2022-10-18 PHASE1
NCT05688085 COMPLETED
Healthy Volunteers
Handok Inc.
 2022-10-18 PHASE1
NCT05663073 COMPLETED
Healthy Volunteers
Handok Inc.
 2022-09-13 PHASE1
NCT05663073 COMPLETED
Healthy Volunteers
Handok Inc.
 2022-09-13 PHASE1
NCT05688098 COMPLETED
Healthy Volunteers
Handok Inc.
 2022-09-23 PHASE1
NCT05688098 COMPLETED
Healthy Volunteers
Handok Inc.
 2022-09-23 PHASE1
NCT05513937 COMPLETED
Hypertension
Menarini International Operations Luxembourg SA
 2022-05-12 PHASE4
NCT05513937 COMPLETED
Hypertension
Menarini International Operations Luxembourg SA
 2022-05-12 PHASE4
NCT06465264 COMPLETED
Essential Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd.
 2021-04-29 PHASE3
NCT06465264 COMPLETED
Essential Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd.
 2021-04-29 PHASE3
NCT04329806 TERMINATED
Obesity-Associated Insulin Resistance
Italo Biaggioni
 2021-02-23 PHASE1
NCT04329806 TERMINATED
Obesity-Associated Insulin Resistance
Italo Biaggioni
 2021-02-23 PHASE1
NCT03666351 COMPLETED
Aortic Stenosis; Aortic Regurgitation; Hypertension; LVM; Left Ventricular Hypertrophy
Hanmi Pharmaceutical Company Limited
 2018-10-18 PHASE4
NCT03666351 COMPLETED
Aortic Stenosis; Aortic Regurgitation; Hypertension; LVM; Left Ventricular Hypertrophy
Hanmi Pharmaceutical Company Limited
 2018-10-18 PHASE4
NCT05189015 COMPLETED
Angiotensin/Renin/Aldosterone Hypertension; Hypertension; Diabetes Mellitus, Type 2
Seoul National University Bundang Hospital
 2021-01-01 PHASE4
NCT05189015 COMPLETED
Angiotensin/Renin/Aldosterone Hypertension; Hypertension; Diabetes Mellitus, Type 2
Seoul National University Bundang Hospital
 2021-01-01 PHASE4
NCT05820880 COMPLETED
Hypertension
Institut de Recherches Internationales Servier
 2019-05-06 PHASE3
NCT05820880 COMPLETED
Hypertension
Institut de Recherches Internationales Servier
 2019-05-06 PHASE3
NCT02913664 COMPLETED
Cognitively Normal Older Adults; Hypertension; Subjective Cognitive Decline; Family History of Alzheimer's Disease
University of Texas Southwestern Medical Center
 2017-02-02 PHASE2; PHASE3
NCT02913664 COMPLETED
Cognitively Normal Older Adults; Hypertension; Subjective Cognitive Decline; Family History of Alzheimer's Disease
University of Texas Southwestern Medical Center
 2017-02-02 PHASE2; PHASE3
NCT04161001 UNKNOWN
Hypertension, Dyslipidemia
Daewoong Pharmaceutical Co. LTD.
 2019-11-20 PHASE3
NCT04161001 UNKNOWN
Hypertension, Dyslipidemia
Daewoong Pharmaceutical Co. LTD.
 2019-11-20 PHASE3
NCT04559074 COMPLETED
Hypertension
Queen Mary University of London
 2020-10-23 PHASE4
NCT04559074 COMPLETED
Hypertension
Queen Mary University of London
 2020-10-23 PHASE4
NCT04488978 COMPLETED
Essential Hypertension
Handok Inc.
 2020-05-21 PHASE2
NCT04488978 COMPLETED
Essential Hypertension
Handok Inc.
 2020-05-21 PHASE2
NCT03951207 COMPLETED
Dyslipidemias; Hypertension
Yuhan Corporation
 2019-05-30 PHASE4
NCT03951207 COMPLETED
Dyslipidemias; Hypertension
Yuhan Corporation
 2019-05-30 PHASE4
NCT04120753 COMPLETED
Hypertension; Dyslipidemias
Daewoong Pharmaceutical Co. LTD.
 2019-08-26 PHASE4
NCT04120753 COMPLETED
Hypertension; Dyslipidemias
Daewoong Pharmaceutical Co. LTD.
 2019-08-26 PHASE4
NCT05470764 COMPLETED
Bioequivalence; Healthy Subjects
Darnitsa Pharmaceutical Company
 2021-05-30 PHASE1
NCT05470764 COMPLETED
Bioequivalence; Healthy Subjects
Darnitsa Pharmaceutical Company
 2021-05-30 PHASE1
NCT03956823 UNKNOWN
Hypertension
First Affiliated Hospital Xi'an Jiaotong University
 2019-08-01
NCT03956823 UNKNOWN
Hypertension
First Affiliated Hospital Xi'an Jiaotong University
 2019-08-01
NCT01996449 COMPLETED
Hypertension
University of Texas Southwestern Medical Center
 2013-07 PHASE2
NCT01996449 COMPLETED
Hypertension
University of Texas Southwestern Medical Center
 2013-07 PHASE2
NCT03783754 TERMINATED
Stroke; Cerebral Small Vessel Diseases; Intracerebral Hemorrhage; Vascular Dementia; Hypertension
The George Institute
 2018-08-09
NCT03783754 TERMINATED
Stroke; Cerebral Small Vessel Diseases; Intracerebral Hemorrhage; Vascular Dementia; Hypertension
The George Institute
 2018-08-09
NCT03991442 COMPLETED
Essential Hypertension
Boryung Pharmaceutical Co., Ltd
 2019-06-17 PHASE3
NCT03991442 COMPLETED
Essential Hypertension
Boryung Pharmaceutical Co., Ltd
 2019-06-17 PHASE3
NCT04218552 COMPLETED
Hypertension,Essential
Addpharma Inc.
 2020-02-25 PHASE2
NCT04218552 COMPLETED
Hypertension,Essential
Addpharma Inc.
 2020-02-25 PHASE2
NCT03785067 TERMINATED
Cognitive Decline; Intracerebral Hemorrhage; Dementia, Vascular; Cerebral Small Vessel Diseases; Hypertension; Stroke Hemorrhagic
The George Institute
 2020-02-27 PHASE3
NCT03785067 TERMINATED
Cognitive Decline; Intracerebral Hemorrhage; Dementia, Vascular; Cerebral Small Vessel Diseases; Hypertension; Stroke Hemorrhagic
The George Institute
 2020-02-27 PHASE3
NCT06713785 WITHDRAWN
Hypertension
Queen Mary University of London
 2020-09-26 PHASE4
NCT06713785 WITHDRAWN
Hypertension
Queen Mary University of London
 2020-09-26 PHASE4
NCT04158076 COMPLETED
Hypercholesterolemia; Hypertension
Addpharma Inc.
 2020-01-23 PHASE3
NCT04158076 COMPLETED
Hypercholesterolemia; Hypertension
Addpharma Inc.
 2020-01-23 PHASE3
NCT02834403 COMPLETED
Metastatic Triple Negative Breast Cancer
The Methodist Hospital Research Institute
 2016-11 PHASE1; PHASE2
NCT02834403 COMPLETED
Metastatic Triple Negative Breast Cancer
The Methodist Hospital Research Institute
 2016-11 PHASE1; PHASE2
NCT03847506 COMPLETED
Hypertension, Hyperlipidemia
HK inno.N Corporation
 2018-07-05 PHASE4
NCT03847506 COMPLETED
Hypertension, Hyperlipidemia
HK inno.N Corporation
 2018-07-05 PHASE4
NCT02940548 TERMINATED
Hypertension
Jing Liu
 2016-12 PHASE4
NCT02940548 TERMINATED
Hypertension
Jing Liu
 2016-12 PHASE4
NCT03461003 COMPLETED
Pediatric Hypertension
The University of Texas Health Science Center, Houston
 2018-04-02 PHASE4
NCT03461003 COMPLETED
Pediatric Hypertension
The University of Texas Health Science Center, Houston
 2018-04-02 PHASE4
NCT04306627 UNKNOWN
Essential Hypertension; Hypercholesterolemia
Yerevan State Medical University
 2020-04-15 PHASE4
NCT04306627 UNKNOWN
Essential Hypertension; Hypercholesterolemia
Yerevan State Medical University
 2020-04-15 PHASE4
NCT03626506 UNKNOWN
Hypertension
Peking University Third Hospital
 2019-02-13
NCT03626506 UNKNOWN
Hypertension
Peking University Third Hospital
 2019-02-13
NCT03978884 WITHDRAWN
Diabetes Mellitus; Hypertension
The University of The West Indies
 2019-06-01 PHASE4
NCT03978884 WITHDRAWN
Diabetes Mellitus; Hypertension
The University of The West Indies
 2019-06-01 PHASE4
NCT04074551 COMPLETED
Hypertension; Dyslipidemias
Hanmi Pharmaceutical Company Limited
 2019-07-16 PHASE3
NCT04074551 COMPLETED
Hypertension; Dyslipidemias
Hanmi Pharmaceutical Company Limited
 2019-07-16 PHASE3
NCT03897868 COMPLETED
Hypertension
Hanmi Pharmaceutical Company Limited
 2019-03-21 PHASE2
NCT03897868 COMPLETED
Hypertension
Hanmi Pharmaceutical Company Limited
 2019-03-21 PHASE2
NCT03667677 UNKNOWN
Hypertension; Anxiety
Chongqing Medical University
 2019-02-01 PHASE4
NCT03667677 UNKNOWN
Hypertension; Anxiety
Chongqing Medical University
 2019-02-01 PHASE4
NCT04521023 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2017-09-20 PHASE4
NCT04521023 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2017-09-20 PHASE4
NCT02046395 COMPLETED
Type 2 Diabetes; Hypertension
Tulane University School of Medicine
 2012-01 PHASE4
NCT02046395 COMPLETED
Type 2 Diabetes; Hypertension
Tulane University School of Medicine
 2012-01 PHASE4
NCT03195023 UNKNOWN
Renal Insufficiency, Chronic; Proteinuria
Hospital General Universitario Gregorio Marañon
 2015-06 PHASE4
NCT03195023 UNKNOWN
Renal Insufficiency, Chronic; Proteinuria
Hospital General Universitario Gregorio Marañon
 2015-06 PHASE4
NCT03578042 UNKNOWN
Hypertension
Hotel Dieu de France Hospital
 2017-04-01 PHASE4
NCT03578042 UNKNOWN
Hypertension
Hotel Dieu de France Hospital
 2017-04-01 PHASE4
NCT03738761 COMPLETED
Hypertension
KRKA
 2018-02-13 PHASE4
NCT03738761 COMPLETED
Hypertension
KRKA
 2018-02-13 PHASE4
NCT04952051 COMPLETED
Hypertension
Second Affiliated Hospital, Zhejiang University, School of Medicine
 2014-07-01 PHASE3
NCT04952051 COMPLETED
Hypertension
Second Affiliated Hospital, Zhejiang University, School of Medicine
 2014-07-01 PHASE3
NCT03474562 COMPLETED
ASCVD; Impaired Fasting Glucose; Hypertension
Yuhan Corporation
 2018-04-03 PHASE4
NCT03474562 COMPLETED
ASCVD; Impaired Fasting Glucose; Hypertension
Yuhan Corporation
 2018-04-03 PHASE4
NCT03231982 UNKNOWN
Hypertension
HK inno.N Corporation
 2017-04-17 PHASE4
NCT03231982 UNKNOWN
Hypertension
HK inno.N Corporation
 2017-04-17 PHASE4
NCT03054467 UNKNOWN
Quality of Life
Kosin University Gospel Hospital
 2018-12-01 PHASE4
NCT03054467 UNKNOWN
Quality of Life
Kosin University Gospel Hospital
 2018-12-01 PHASE4
NCT04262765 COMPLETED
Healthy Volunteers
Midas Pharma GmbH
 2019-02-23 PHASE1
NCT04262765 COMPLETED
Healthy Volunteers
Midas Pharma GmbH
 2019-02-23 PHASE1
NCT02710539 UNKNOWN
Arterial Hypertension
University of Roma La Sapienza
 2016-04 PHASE4
NCT02710539 UNKNOWN
Arterial Hypertension
University of Roma La Sapienza
 2016-04 PHASE4
NCT02710552 UNKNOWN
Arterial Hypertension
University of Roma La Sapienza
 2016-04 PHASE4
NCT02710552 UNKNOWN
Arterial Hypertension
University of Roma La Sapienza
 2016-04 PHASE4
NCT03707899 COMPLETED
Hypertension With Dyslipidemia
Jeil Pharmaceutical Co., Ltd.
 2018-12-13 PHASE1
NCT03707899 COMPLETED
Hypertension With Dyslipidemia
Jeil Pharmaceutical Co., Ltd.
 2018-12-13 PHASE1
NCT04245046 COMPLETED
Healthy Volunteers
Midas Pharma GmbH
 2019-01-18 PHASE1
NCT04245046 COMPLETED
Healthy Volunteers
Midas Pharma GmbH
 2019-01-18 PHASE1
NCT03626259 UNKNOWN
Hypertension
Centro Universitario de Ciencias de la Salud, Mexico
 2018-08-06 PHASE4
NCT04411875 COMPLETED
Healthy Subjects
The Affiliated Hospital of Qingdao University
 2018-11-13 PHASE1
NCT03626259 UNKNOWN
Hypertension
Centro Universitario de Ciencias de la Salud, Mexico
 2018-08-06 PHASE4
NCT04411875 COMPLETED
Healthy Subjects
The Affiliated Hospital of Qingdao University
 2018-11-13 PHASE1
NCT02996916 UNKNOWN
Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension
Kurume University
 2015-12 PHASE4
NCT02996916 UNKNOWN
Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension
Kurume University
 2015-12 PHASE4
NCT03639480 UNKNOWN
Hypertension; Hyperlipidemia
HK inno.N Corporation
 2017-10-13 PHASE3
NCT03639480 UNKNOWN
Hypertension; Hyperlipidemia
HK inno.N Corporation
 2017-10-13 PHASE3
NCT02969265 WITHDRAWN
Hypertension
Takeda
 2017-05-09 PHASE3
NCT02969265 WITHDRAWN
Hypertension
Takeda
 2017-05-09 PHASE3
NCT02278471 COMPLETED
Hypertension; Hyperlipidemia
Vanderbilt University
 2015-12 PHASE2
NCT02278471 COMPLETED
Hypertension; Hyperlipidemia
Vanderbilt University
 2015-12 PHASE2
NCT02742467 COMPLETED
Hypertension
University of Abuja
 2017-06-07 PHASE4
NCT02742467 COMPLETED
Hypertension
University of Abuja
 2017-06-07 PHASE4
NCT01922141 WITHDRAWN
Hypertension
Novartis Pharmaceuticals
 2015-05 PHASE4
NCT01922141 WITHDRAWN
Hypertension
Novartis Pharmaceuticals
 2015-05 PHASE4
NCT02671695 COMPLETED
Beta Thalassemia Major
Tanta University
 2015-04
NCT03009487 COMPLETED
Hypertension; Hyperlipidemias
Daewoong Pharmaceutical Co. LTD.
 2017-01 PHASE3
NCT02671695 COMPLETED
Beta Thalassemia Major
Tanta University
 2015-04
NCT03009487 COMPLETED
Hypertension; Hyperlipidemias
Daewoong Pharmaceutical Co. LTD.
 2017-01 PHASE3
NCT03226340 UNKNOWN
Essential Hypertension
Seoul National University Bundang Hospital
 2015-12-02 PHASE4
NCT03226340 UNKNOWN
Essential Hypertension
Seoul National University Bundang Hospital
 2015-12-02 PHASE4
NCT03067688 COMPLETED
Hypertension; Hyperlipidemia
Yuhan Corporation
 2017-04-11 PHASE3
NCT03067688 COMPLETED
Hypertension; Hyperlipidemia
Yuhan Corporation
 2017-04-11 PHASE3
NCT02231788 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2014-06 PHASE4
NCT02231788 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2014-06 PHASE4
NCT03294070 UNKNOWN
Arterial Hypertension
Centro Universitario de Ciencias de la Salud, Mexico
 2017-09 PHASE4
NCT03294070 UNKNOWN
Arterial Hypertension
Centro Universitario de Ciencias de la Salud, Mexico
 2017-09 PHASE4
NCT03753477 COMPLETED
Healthy
Daewoong Pharmaceutical Co. LTD.
 2017-12-22 PHASE1
NCT03753477 COMPLETED
Healthy
Daewoong Pharmaceutical Co. LTD.
 2017-12-22 PHASE1
NCT03390465 COMPLETED
Drug-Drug Interaction
Boryung Pharmaceutical Co., Ltd
 2017-12-15 PHASE1
NCT03390465 COMPLETED
Drug-Drug Interaction
Boryung Pharmaceutical Co., Ltd
 2017-12-15 PHASE1
NCT01198496 UNKNOWN
Hypertension; Stroke; Blood Pressure
Biomedis International Ltd.
 2010-10 PHASE4
NCT02378064 COMPLETED
Inflammation Plaque, Atherosclerotic; Coronary Disease; Renin-Angiotensin System
CHEOL WHAN LEE, M.D., Ph.D
 2015-05 PHASE4
NCT02378064 COMPLETED
Inflammation Plaque, Atherosclerotic; Coronary Disease; Renin-Angiotensin System
CHEOL WHAN LEE, M.D., Ph.D
 2015-05 PHASE4
NCT01198496 UNKNOWN
Hypertension; Stroke; Blood Pressure
Biomedis International Ltd.
 2010-10 PHASE4
NCT02526875 UNKNOWN
Hypertension
Chong Kun Dang Pharmaceutical
 2015-04 PHASE4
NCT02526875 UNKNOWN
Hypertension
Chong Kun Dang Pharmaceutical
 2015-04 PHASE4
NCT03226275 COMPLETED
Healthy
Merck KGaA, Darmstadt, Germany
 2017-08-09 PHASE1
NCT03226275 COMPLETED
Healthy
Merck KGaA, Darmstadt, Germany
 2017-08-09 PHASE1
NCT03536598 COMPLETED
Hypertension With Hyperlipidemia
HK inno.N Corporation
 2016-10-14 PHASE3
NCT03536598 COMPLETED
Hypertension With Hyperlipidemia
HK inno.N Corporation
 2016-10-14 PHASE3
NCT03210532 COMPLETED
Hypertension; Dyslipidemia
Daewon Pharmaceutical Co., Ltd.
 2016-10-07 PHASE3
NCT03210532 COMPLETED
Hypertension; Dyslipidemia
Daewon Pharmaceutical Co., Ltd.
 2016-10-07 PHASE3
NCT02744456 COMPLETED
Hypertension; High Blood Pressure
Columbia University
 2014-08-01 EARLY_PHASE1
NCT02744456 COMPLETED
Hypertension; High Blood Pressure
Columbia University
 2014-08-01 EARLY_PHASE1
NCT03247140 COMPLETED
Hypertension With Dyslipidemia
Jeil Pharmaceutical Co., Ltd.
 2017-06-10 PHASE1
NCT03247140 COMPLETED
Hypertension With Dyslipidemia
Jeil Pharmaceutical Co., Ltd.
 2017-06-10 PHASE1
NCT02900729 UNKNOWN
Hypertension
Shanghai WiseGain Medical Devices Co., Ltd.
 2016-10 PHASE3
NCT02900729 UNKNOWN
Hypertension
Shanghai WiseGain Medical Devices Co., Ltd.
 2016-10 PHASE3
NCT03088254 COMPLETED
Dyslipidemia With Hypertension
Jeil Pharmaceutical Co., Ltd.
 2016-09-20 PHASE3
NCT03088254 COMPLETED
Dyslipidemia With Hypertension
Jeil Pharmaceutical Co., Ltd.
 2016-09-20 PHASE3
NCT03461081 COMPLETED
Hypertension With Hyperlipidemia
Jeil Pharmaceutical Co., Ltd.
 2017-05-07 PHASE1
NCT03461081 COMPLETED
Hypertension With Hyperlipidemia
Jeil Pharmaceutical Co., Ltd.
 2017-05-07 PHASE1
NCT03566316 COMPLETED
Hypertension With Hyperlipidemia
IlDong Pharmaceutical Co Ltd
 2015-11-24 PHASE3
NCT03566316 COMPLETED
Hypertension With Hyperlipidemia
IlDong Pharmaceutical Co Ltd
 2015-11-24 PHASE3
NCT02474420 UNKNOWN
Beta-Thalassemia; Iron Overload
Kevin H.M. Kuo, MD, MSc, FRCPC
 2015-06
NCT02474420 UNKNOWN
Beta-Thalassemia; Iron Overload
Kevin H.M. Kuo, MD, MSc, FRCPC
 2015-06
NCT03747978 COMPLETED
Diabetes Mellitus, Type 2; Hypertension
Yaounde Central Hospital
 2016-10-01 PHASE4
NCT02377661 COMPLETED
Hypertension
Wilhelminenspital Vienna
 2015-03 PHASE4
NCT03747978 COMPLETED
Diabetes Mellitus, Type 2; Hypertension
Yaounde Central Hospital
 2016-10-01 PHASE4
NCT02377661 COMPLETED
Hypertension
Wilhelminenspital Vienna
 2015-03 PHASE4
NCT03116516 COMPLETED
Hypertension; Hyperlipidemia
Yuhan Corporation
 2017-04-21 PHASE1
NCT03116516 COMPLETED
Hypertension; Hyperlipidemia
Yuhan Corporation
 2017-04-21 PHASE1
NCT01964079 COMPLETED
Hypertension
Wonju Severance Christian Hospital
 2013-04 PHASE4
NCT01964079 COMPLETED
Hypertension
Wonju Severance Christian Hospital
 2013-04 PHASE4
NCT02974439 COMPLETED
Bioequivalence
Shanghai Haini Pharmaceutical Co., Ltd.
 2016-12-23 PHASE1
NCT02974439 COMPLETED
Bioequivalence
Shanghai Haini Pharmaceutical Co., Ltd.
 2016-12-23 PHASE1
NCT03038451 COMPLETED
Hypertension
Neutec Ar-Ge San ve Tic A.Ş
 2013-03-20 PHASE4
NCT03038451 COMPLETED
Hypertension
Neutec Ar-Ge San ve Tic A.Ş
 2013-03-20 PHASE4
NCT02988362 COMPLETED
Hypertension
HanAll BioPharma Co., Ltd.
 2016-12-14 PHASE1
NCT02988362 COMPLETED
Hypertension
HanAll BioPharma Co., Ltd.
 2016-12-14 PHASE1
NCT02920047 COMPLETED
Hypertension
Boryung Pharmaceutical Co., Ltd
 2016-10 PHASE1
NCT02920047 COMPLETED
Hypertension
Boryung Pharmaceutical Co., Ltd
 2016-10 PHASE1
NCT03032315 COMPLETED
Healthy
IlDong Pharmaceutical Co Ltd
 2016-10-01 PHASE1
NCT03032315 COMPLETED
Healthy
IlDong Pharmaceutical Co Ltd
 2016-10-01 PHASE1
NCT02620163 COMPLETED
Hypertension
Yuhan Corporation
 2015-12 PHASE3
NCT02312375 COMPLETED
Diabetes Mellitus; Hypertension
Seoul National University Hospital
 2015-03
NCT02620163 COMPLETED
Hypertension
Yuhan Corporation
 2015-12 PHASE3
NCT02312375 COMPLETED
Diabetes Mellitus; Hypertension
Seoul National University Hospital
 2015-03
NCT02995720 COMPLETED
Hypertension, Hyperlipidemia
Boryung Pharmaceutical Co., Ltd
 2016-08-26 PHASE1
NCT02995720 COMPLETED
Hypertension, Hyperlipidemia
Boryung Pharmaceutical Co., Ltd
 2016-08-26 PHASE1
NCT03657472 COMPLETED
Hypertension; Hyperlipidemia
HK inno.N Corporation
 2016-09-19 PHASE1
NCT03657472 COMPLETED
Hypertension; Hyperlipidemia
HK inno.N Corporation
 2016-09-19 PHASE1
NCT02814500 UNKNOWN
Healthy
Alvogen Korea
 2016-07 PHASE1
NCT02814500 UNKNOWN
Healthy
Alvogen Korea
 2016-07 PHASE1
NCT02213224 UNKNOWN
Nonalcoholic Fatty Liver Disease (NAFLD)
Nanfang Hospital, Southern Medical University
 2014-08 PHASE4
NCT02213224 UNKNOWN
Nonalcoholic Fatty Liver Disease (NAFLD)
Nanfang Hospital, Southern Medical University
 2014-08 PHASE4
NCT02951962 COMPLETED
Hypertension; Hyperlipidemia
Yuhan Corporation
 2016-08 PHASE1
NCT02951962 COMPLETED
Hypertension; Hyperlipidemia
Yuhan Corporation
 2016-08 PHASE1
NCT02738632 COMPLETED
Essential Hypertension
IlDong Pharmaceutical Co Ltd
 2015-05 PHASE3
NCT02586311 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2016-01 PHASE3
NCT02586311 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2016-01 PHASE3
NCT02738632 COMPLETED
Essential Hypertension
IlDong Pharmaceutical Co Ltd
 2015-05 PHASE3
NCT02412761 COMPLETED
Essential Hypertension
The University of Texas Health Science Center, Houston
 2013-06
NCT02412761 COMPLETED
Essential Hypertension
The University of Texas Health Science Center, Houston
 2013-06
NCT02789475 UNKNOWN
Hypertension; Hyperlipidemias
Alvogen Korea
 2016-05 PHASE1
NCT02789475 UNKNOWN
Hypertension; Hyperlipidemias
Alvogen Korea
 2016-05 PHASE1
NCT02665832 UNKNOWN
Healthy
Daewoong Pharmaceutical Co. LTD.
 2016-01 PHASE1
NCT02665832 UNKNOWN
Healthy
Daewoong Pharmaceutical Co. LTD.
 2016-01 PHASE1
NCT02608242 TERMINATED
Hypertension; Hyperlipidemia
Yuhan Corporation
 2015-11 PHASE1
NCT02608242 TERMINATED
Hypertension; Hyperlipidemia
Yuhan Corporation
 2015-11 PHASE1
NCT01996085 COMPLETED
Arterial Hypertension
Military Institute od Medicine National Research Institute
 2013-01
NCT01996085 COMPLETED
Arterial Hypertension
Military Institute od Medicine National Research Institute
 2013-01
NCT02294539 COMPLETED
Hypertension
Chong-Jin Kim
 2014-08 PHASE4
NCT02294539 COMPLETED
Hypertension
Chong-Jin Kim
 2014-08 PHASE4
NCT02373163 COMPLETED
Blood Pressure, High
Prevencion
 2014-09-01 PHASE4
NCT02373163 COMPLETED
Blood Pressure, High
Prevencion
 2014-09-01 PHASE4
NCT02651870 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2015-04-22 PHASE3
NCT02651870 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2015-04-22 PHASE3
NCT02896621 COMPLETED
Hypertension; Sleep Apnea
Hospital de Clinicas de Porto Alegre
 2014-12-07 PHASE3
NCT02896621 COMPLETED
Hypertension; Sleep Apnea
Hospital de Clinicas de Porto Alegre
 2014-12-07 PHASE3
NCT02734355 COMPLETED
Atrial Fibrillation
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
 2015-11 PHASE4
NCT02734355 COMPLETED
Atrial Fibrillation
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
 2015-11 PHASE4
NCT02644395 COMPLETED
Hypertension; Kidney Transplantation
Erasmus Medical Center
 2013-01-18 PHASE3
NCT02644395 COMPLETED
Hypertension; Kidney Transplantation
Erasmus Medical Center
 2013-01-18 PHASE3
NCT02569814 COMPLETED
Hypertension; Hyperlipidemia
Boryung Pharmaceutical Co., Ltd
 2015-09 PHASE1
NCT02995954 COMPLETED
Hypertension
Guido Iaccarino
 2014-01 PHASE4
NCT02995954 COMPLETED
Hypertension
Guido Iaccarino
 2014-01 PHASE4
NCT02944734 COMPLETED
Essential Hypertension
Shin Poong Pharmaceutical Co. Ltd.
 2014-09 PHASE2
NCT02944734 COMPLETED
Essential Hypertension
Shin Poong Pharmaceutical Co. Ltd.
 2014-09 PHASE2
NCT02569814 COMPLETED
Hypertension; Hyperlipidemia
Boryung Pharmaceutical Co., Ltd
 2015-09 PHASE1
NCT02172040 COMPLETED
Hypertension
Kitov Pharmaceuticals, Ltd.
 2014-06-26 PHASE3
NCT02172040 COMPLETED
Hypertension
Kitov Pharmaceuticals, Ltd.
 2014-06-26 PHASE3
NCT02933658 COMPLETED
Hypertension and Dyslipidemia
Daewon Pharmaceutical Co., Ltd.
 2015-11 PHASE1
NCT02933658 COMPLETED
Hypertension and Dyslipidemia
Daewon Pharmaceutical Co., Ltd.
 2015-11 PHASE1
NCT02368652 COMPLETED
Essential Hypertension
HK inno.N Corporation
 2014-12 PHASE3
NCT02368665 COMPLETED
Essential Hypertension
HK inno.N Corporation
 2014-12 PHASE3
NCT02368652 COMPLETED
Essential Hypertension
HK inno.N Corporation
 2014-12 PHASE3
NCT02368665 COMPLETED
Essential Hypertension
HK inno.N Corporation
 2014-12 PHASE3
NCT02065492 COMPLETED
Thalassemia
Aga Khan University
 2014-02 PHASE2; PHASE3
NCT02065492 COMPLETED
Thalassemia
Aga Khan University
 2014-02 PHASE2; PHASE3
NCT02496910 COMPLETED
Hypertension
Yuhan Corporation
 2015-06 PHASE1
NCT02496910 COMPLETED
Hypertension
Yuhan Corporation
 2015-06 PHASE1
NCT01365481 COMPLETED
Hypertension; Chronic Kidney Disease
Novartis Pharmaceuticals
 2011-08 PHASE3
NCT01365481 COMPLETED
Hypertension; Chronic Kidney Disease
Novartis Pharmaceuticals
 2011-08 PHASE3
NCT02062645 COMPLETED
Essential Hypertension
Novartis Pharmaceuticals
 2014-02 PHASE4
NCT02121041 COMPLETED
Hypertension
Anthony J Viera, MD, MPH
 2014-05
NCT02062645 COMPLETED
Essential Hypertension
Novartis Pharmaceuticals
 2014-02 PHASE4
NCT02121041 COMPLETED
Hypertension
Anthony J Viera, MD, MPH
 2014-05
NCT02544776 COMPLETED
Female Infertility Associated With Anovulation
Ahmed Fathy Ali Mohamed Ghanem
 2015-01
NCT02544776 COMPLETED
Female Infertility Associated With Anovulation
Ahmed Fathy Ali Mohamed Ghanem
 2015-01
NCT02548286 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2015-08 PHASE1
NCT02548286 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2015-08 PHASE1
NCT02059616 UNKNOWN
Essential Hypertension
HK inno.N Corporation
 2014-02 PHASE2
NCT01870739 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2013-10 PHASE2
NCT01870739 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2013-10 PHASE2
NCT02059616 UNKNOWN
Essential Hypertension
HK inno.N Corporation
 2014-02 PHASE2
NCT02811731 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2015-04 PHASE1
NCT02811731 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2015-04 PHASE1
NCT01118520 COMPLETED
Abdominal Aortic Aneurysm
Imperial College London
 2011-09 PHASE2
NCT01118520 COMPLETED
Abdominal Aortic Aneurysm
Imperial College London
 2011-09 PHASE2
NCT01865188 WITHDRAWN
Hypertension
Novartis Pharmaceuticals
 2014-04 PHASE3
NCT01692301 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2012-12 PHASE2
NCT01865188 WITHDRAWN
Hypertension
Novartis Pharmaceuticals
 2014-04 PHASE3
NCT01692301 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2012-12 PHASE2
NCT02206165 UNKNOWN
Essential Hypertension
Chong Kun Dang Pharmaceutical
 2014-03 PHASE2
NCT02206165 UNKNOWN
Essential Hypertension
Chong Kun Dang Pharmaceutical
 2014-03 PHASE2
NCT01977794 COMPLETED
Hypertension
Merck KGaA, Darmstadt, Germany
 2014-03 PHASE3
NCT01977794 COMPLETED
Hypertension
Merck KGaA, Darmstadt, Germany
 2014-03 PHASE3
NCT02387619 COMPLETED
Hypertension; Hyperlipidemia
Jeil Pharmaceutical Co., Ltd.
 2015-02 PHASE1
NCT02387619 COMPLETED
Hypertension; Hyperlipidemia
Jeil Pharmaceutical Co., Ltd.
 2015-02 PHASE1
NCT01603940 COMPLETED
Hypertension; Diabetes Mellitus
Hospital Universitario Pedro Ernesto
 2012-05 PHASE4
NCT01911780 COMPLETED
Hypertension
Boehringer Ingelheim
 2013-07 PHASE3
NCT01603940 COMPLETED
Hypertension; Diabetes Mellitus
Hospital Universitario Pedro Ernesto
 2012-05 PHASE4
NCT01911780 COMPLETED
Hypertension
Boehringer Ingelheim
 2013-07 PHASE3
NCT02250833 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2014-09 PHASE1
NCT02250833 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2014-09 PHASE1
NCT01120327 COMPLETED
Coronary Artery Disease
Seoul National University Hospital
 2011-09 PHASE4
NCT01120327 COMPLETED
Coronary Artery Disease
Seoul National University Hospital
 2011-09 PHASE4
NCT01819220 COMPLETED
Hypertension
Yonsei University
 2009-04 PHASE4
NCT01819220 COMPLETED
Hypertension
Yonsei University
 2009-04 PHASE4
NCT02233218 COMPLETED
Healthy Male Volunteer
Yuhan Corporation
 2014-07 PHASE1
NCT02233218 COMPLETED
Healthy Male Volunteer
Yuhan Corporation
 2014-07 PHASE1
NCT02183675 COMPLETED
Healthy
Boehringer Ingelheim
 2014-07 PHASE1
NCT02183675 COMPLETED
Healthy
Boehringer Ingelheim
 2014-07 PHASE1
NCT01983735 UNKNOWN
Hypertension
Chong Kun Dang Pharmaceutical
 2014-01 PHASE3
NCT02064621 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2014-06 PHASE1
NCT02121535 COMPLETED
Healthy
Boehringer Ingelheim
 2014-04 PHASE1
NCT02121535 COMPLETED
Healthy
Boehringer Ingelheim
 2014-04 PHASE1
NCT01665235 UNKNOWN
Blood Pressure Variability; Intracranial Artery Stenosis
RenJi Hospital
 2012-08
NCT01838850 COMPLETED
Essential Hypertension
Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company
 2013-04 PHASE3
NCT02186496 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2014-07 PHASE1
NCT01665235 UNKNOWN
Blood Pressure Variability; Intracranial Artery Stenosis
RenJi Hospital
 2012-08
NCT01838850 COMPLETED
Essential Hypertension
Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company
 2013-04 PHASE3
NCT02173912 UNKNOWN
Healthy Volunteers
HK inno.N Corporation
 2014-06 PHASE1
NCT02186496 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2014-07 PHASE1
NCT02129192 COMPLETED
Healthy
Boehringer Ingelheim
 2014-05 PHASE1
NCT02173912 UNKNOWN
Healthy Volunteers
HK inno.N Corporation
 2014-06 PHASE1
NCT02129192 COMPLETED
Healthy
Boehringer Ingelheim
 2014-05 PHASE1
NCT02152969 COMPLETED
Hypertension
Yuhan Corporation
 2014-05 PHASE1
NCT01983735 UNKNOWN
Hypertension
Chong Kun Dang Pharmaceutical
 2014-01 PHASE3
NCT02152969 COMPLETED
Hypertension
Yuhan Corporation
 2014-05 PHASE1
NCT02064621 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2014-06 PHASE1
NCT02058823 TERMINATED
Hypoxia; Sleep Apnea; Obstructive Sleep Apnea
University Hospital, Grenoble
 2013-08-07 PHASE4
NCT02058823 TERMINATED
Hypoxia; Sleep Apnea; Obstructive Sleep Apnea
University Hospital, Grenoble
 2013-08-07 PHASE4
NCT02075619 COMPLETED
Hypertension
GlaxoSmithKline
 2014-03-24 PHASE1
NCT02075619 COMPLETED
Hypertension
GlaxoSmithKline
 2014-03-24 PHASE1
NCT01835418 UNKNOWN
Hypertension
Allina Health System
 2013-04
NCT01658657 COMPLETED
Hypertension; Plasma Renin Activity
University of North Carolina, Chapel Hill
 2012-10
NCT01835418 UNKNOWN
Hypertension
Allina Health System
 2013-04
NCT01658657 COMPLETED
Hypertension; Plasma Renin Activity
University of North Carolina, Chapel Hill
 2012-10
NCT02064556 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2014-05 PHASE1
NCT02064556 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2014-05 PHASE1
NCT01490255 UNKNOWN
Coronary Artery Disease
University of Roma La Sapienza
 2012-01 PHASE4
NCT01490255 UNKNOWN
Coronary Artery Disease
University of Roma La Sapienza
 2012-01 PHASE4
NCT01975246 COMPLETED
Hypertension
Boehringer Ingelheim
 2013-11 PHASE3
NCT01975246 COMPLETED
Hypertension
Boehringer Ingelheim
 2013-11 PHASE3
NCT01614366 COMPLETED
Hypertension
TSH Biopharm Corporation Limited
 2012-07 PHASE2
NCT01614366 COMPLETED
Hypertension
TSH Biopharm Corporation Limited
 2012-07 PHASE2
NCT02140489 UNKNOWN
Healthy
Hanmi Pharmaceutical Company Limited
 2014-02 PHASE1
NCT02140489 UNKNOWN
Healthy
Hanmi Pharmaceutical Company Limited
 2014-02 PHASE1
NCT00805311 TERMINATED
Carotid Artery Stenosis; Atherosclerosis; Stroke
Russian Cardiology Research and Production Center
 2009-04 PHASE4
NCT00805311 TERMINATED
Carotid Artery Stenosis; Atherosclerosis; Stroke
Russian Cardiology Research and Production Center
 2009-04 PHASE4
NCT01557153 UNKNOWN
Depression
Gateshead Health NHS Foundation Trust
 2012-04 PHASE3
NCT01557153 UNKNOWN
Depression
Gateshead Health NHS Foundation Trust
 2012-04 PHASE3
NCT00825188 TERMINATED
Obesity; Hypertension
University of Mississippi Medical Center
 2009-01
NCT02047175 COMPLETED
Hypertension; Hyperlipidemia
Chong Kun Dang Pharmaceutical
 2014-02 PHASE1
NCT00825188 TERMINATED
Obesity; Hypertension
University of Mississippi Medical Center
 2009-01
NCT02047175 COMPLETED
Hypertension; Hyperlipidemia
Chong Kun Dang Pharmaceutical
 2014-02 PHASE1
NCT02058446 COMPLETED
Essential Hypertension
TSH Biopharm Corporation Limited
 2013-10 PHASE4
NCT02058446 COMPLETED
Essential Hypertension
TSH Biopharm Corporation Limited
 2013-10 PHASE4
NCT02069821 COMPLETED
Healthy
HK inno.N Corporation
 2014-03 PHASE1
NCT02069821 COMPLETED
Healthy
HK inno.N Corporation
 2014-03 PHASE1
NCT03889145 COMPLETED
Healthy
IlDong Pharmaceutical Co Ltd
 2013-12-19 PHASE1
NCT03889145 COMPLETED
Healthy
IlDong Pharmaceutical Co Ltd
 2013-12-19 PHASE1
NCT01354613 COMPLETED
Heart Failure With Preserved Ejection Fraction; Pulmonary Disease; Left Ventricular Hypertrophy/Hypertension
University of Wisconsin, Madison
 2011-04
NCT01956786 UNKNOWN
Essential Hypertension
Shenzhen Ausa Pharmed Co.,Ltd
 2013-09 PHASE2; PHASE3
NCT01354613 COMPLETED
Heart Failure With Preserved Ejection Fraction; Pulmonary Disease; Left Ventricular Hypertrophy/Hypertension
University of Wisconsin, Madison
 2011-04
NCT01762501 COMPLETED
Hypertension
Sogo Rinsho Médéfi Co., Ltd.
 2012-12
NCT01425242 TERMINATED
Hypertension; Abdominal Aortic Aneurysm
Amsterdam UMC, location VUmc
 2011-09
NCT01762501 COMPLETED
Hypertension
Sogo Rinsho Médéfi Co., Ltd.
 2012-12
NCT01425242 TERMINATED
Hypertension; Abdominal Aortic Aneurysm
Amsterdam UMC, location VUmc
 2011-09
NCT01956786 UNKNOWN
Essential Hypertension
Shenzhen Ausa Pharmed Co.,Ltd
 2013-09 PHASE2; PHASE3
NCT01748253 UNKNOWN
Hypertension and Atrial Fibrillation
Acrobat Trial Group
 2012-11
NCT01518998 COMPLETED
Hypertension
Boryung Pharmaceutical Co., Ltd
 2011-08 PHASE2
NCT01748253 UNKNOWN
Hypertension and Atrial Fibrillation
Acrobat Trial Group
 2012-11
NCT01518998 COMPLETED
Hypertension
Boryung Pharmaceutical Co., Ltd
 2011-08 PHASE2
NCT01806311 COMPLETED
Hypertension
HanAll BioPharma Co., Ltd.
 2012-12 PHASE1
NCT01848873 UNKNOWN
Essential Hypertension
Shenzhen Ausa Pharmed Co.,Ltd
 2013-01 PHASE2; PHASE3
NCT01806311 COMPLETED
Hypertension
HanAll BioPharma Co., Ltd.
 2012-12 PHASE1
NCT01848873 UNKNOWN
Essential Hypertension
Shenzhen Ausa Pharmed Co.,Ltd
 2013-01 PHASE2; PHASE3
NCT01631864 COMPLETED
Hypertension; Concurrent Obesity
Novartis Pharmaceuticals
 2012-10 PHASE2
NCT01845272 UNKNOWN
Healthy
HK inno.N Corporation
 2013-04 PHASE1
NCT01631864 COMPLETED
Hypertension; Concurrent Obesity
Novartis Pharmaceuticals
 2012-10 PHASE2
NCT01845272 UNKNOWN
Healthy
HK inno.N Corporation
 2013-04 PHASE1
NCT01822639 COMPLETED
Hypertension
GlaxoSmithKline
 2013-04-03 PHASE1
NCT01822639 COMPLETED
Hypertension
GlaxoSmithKline
 2013-04-03 PHASE1
NCT01842230 COMPLETED
Essential Hypertension; Hyperlipidemia
Chong Kun Dang Pharmaceutical
 2013-04 PHASE1
NCT01842230 COMPLETED
Essential Hypertension; Hyperlipidemia
Chong Kun Dang Pharmaceutical
 2013-04 PHASE1
NCT01663233 COMPLETED
Essential Hypertension
Novartis Pharmaceuticals
 2012-08 PHASE3
NCT01842256 COMPLETED
Essential Hypertension; Hyperlipidemia
Chong Kun Dang Pharmaceutical
 2013-04 PHASE1
NCT01663233 COMPLETED
Essential Hypertension
Novartis Pharmaceuticals
 2012-08 PHASE3
NCT01842256 COMPLETED
Essential Hypertension; Hyperlipidemia
Chong Kun Dang Pharmaceutical
 2013-04 PHASE1
NCT01277822 COMPLETED
Hypertension
Organon and Co
 2011-05-30 PHASE4
NCT01277822 COMPLETED
Hypertension
Organon and Co
 2011-05-30 PHASE4
NCT01409408 WITHDRAWN
Hypertension; Diabetes Mellitus
Hospital Universitario Pedro Ernesto
 2011-04 PHASE4
NCT01409408 WITHDRAWN
Hypertension; Diabetes Mellitus
Hospital Universitario Pedro Ernesto
 2011-04 PHASE4
NCT01030081 COMPLETED
Hypertension
Shanghai Jiao Tong University School of Medicine
 2009-10 PHASE4
NCT01030081 COMPLETED
Hypertension
Shanghai Jiao Tong University School of Medicine
 2009-10 PHASE4
NCT01556997 COMPLETED
Essential Hypertension
Symplmed Pharmaceuticals LLC
 2012-02 PHASE3
NCT01556997 COMPLETED
Essential Hypertension
Symplmed Pharmaceuticals LLC
 2012-02 PHASE3
NCT01625494 COMPLETED
Hypertension
Sanofi
 2012-05 PHASE3
NCT01625494 COMPLETED
Hypertension
Sanofi
 2012-05 PHASE3
NCT00987662 WITHDRAWN
Obesity; Hypertension
Aristotle University Of Thessaloniki
 2012-01 PHASE4
NCT00987662 WITHDRAWN
Obesity; Hypertension
Aristotle University Of Thessaloniki
 2012-01 PHASE4
NCT01252238 TERMINATED
Insulin Sensitivity; Aortic Compliance; Diastolic Function
Brigham and Women's Hospital
 2010-06
NCT01611077 COMPLETED
Hypertension
Institut für Pharmakologie und Präventive Medizin
 2012-01 PHASE4
NCT01252238 TERMINATED
Insulin Sensitivity; Aortic Compliance; Diastolic Function
Brigham and Women's Hospital
 2010-06
NCT01611077 COMPLETED
Hypertension
Institut für Pharmakologie und Präventive Medizin
 2012-01 PHASE4
NCT01735890 COMPLETED
Healthy
HK inno.N Corporation
 2012-09 PHASE1
NCT01735890 COMPLETED
Healthy
HK inno.N Corporation
 2012-09 PHASE1
NCT01259297 TERMINATED
Cardiovascular Events
Novartis Pharmaceuticals
 2011-01 PHASE3
NCT01259297 TERMINATED
Cardiovascular Events
Novartis Pharmaceuticals
 2011-01 PHASE3
NCT01101009 COMPLETED
Hypertension
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
 2010-04 PHASE4
NCT01101009 COMPLETED
Hypertension
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
 2010-04 PHASE4
NCT01255475 COMPLETED
Heart Failure; Cardiac Failure; Congestive Heart Failure
University of Sao Paulo
 2011-01 PHASE2; PHASE3
NCT01255475 COMPLETED
Heart Failure; Cardiac Failure; Congestive Heart Failure
University of Sao Paulo
 2011-01 PHASE2; PHASE3
NCT01648231 COMPLETED
Hypertension
GlaxoSmithKline
 2012-08-06 PHASE1
NCT01648231 COMPLETED
Hypertension
GlaxoSmithKline
 2012-08-06 PHASE1
NCT01549496 WITHDRAWN
Hepatitis C; Hypertension
Ottawa Hospital Research Institute
 2012-05 PHASE1
NCT01549496 WITHDRAWN
Hepatitis C; Hypertension
Ottawa Hospital Research Institute
 2012-05 PHASE1
NCT01394770 UNKNOWN
Hypertension; Dialysis
University of Campania Luigi Vanvitelli
 2009-09 PHASE4
NCT01394770 UNKNOWN
Hypertension; Dialysis
University of Campania Luigi Vanvitelli
 2009-09 PHASE4
NCT01613209 COMPLETED
Hypertension
Institut für Pharmakologie und Präventive Medizin
 2011-12 PHASE3
NCT01501253 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2011-08 PHASE3
NCT01613209 COMPLETED
Hypertension
Institut für Pharmakologie und Präventive Medizin
 2011-12 PHASE3
NCT01501253 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2011-08 PHASE3
NCT01011660 UNKNOWN
Essential Hypertension
Chinese Academy of Medical Sciences, Fuwai Hospital
 2007-10 PHASE4
NCT01011660 UNKNOWN
Essential Hypertension
Chinese Academy of Medical Sciences, Fuwai Hospital
 2007-10 PHASE4
NCT00509470 COMPLETED
Essential Hypertension
Tokyo University
 2007-07 PHASE4
NCT00509470 COMPLETED
Essential Hypertension
Tokyo University
 2007-07 PHASE4
NCT01426100 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2011-08 PHASE3
NCT01426100 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2011-08 PHASE3
NCT04740840 COMPLETED
Hypertension
Affiliated Hospital of North Sichuan Medical College
 2010-05-01 PHASE2; PHASE3
NCT04740840 COMPLETED
Hypertension
Affiliated Hospital of North Sichuan Medical College
 2010-05-01 PHASE2; PHASE3
NCT01302691 COMPLETED
Hypertension
Merck Sharp & Dohme LLC
 2011-01-01 PHASE3
NCT01302691 COMPLETED
Hypertension
Merck Sharp & Dohme LLC
 2011-01-01 PHASE3
NCT01494727 COMPLETED
Healthy
HK inno.N Corporation
 2012-02 PHASE1
NCT01494727 COMPLETED
Healthy
HK inno.N Corporation
 2012-02 PHASE1
NCT01256411 COMPLETED
Essential Hypertension
Novartis Pharmaceuticals
 2010-11 PHASE2
NCT01256411 COMPLETED
Essential Hypertension
Novartis Pharmaceuticals
 2010-11 PHASE2
NCT01030458 COMPLETED
Blood Pressure
KU Leuven
 2010-09 PHASE4
NCT00498433 TERMINATED
Hypertension; Abdominal Obesity
Novartis
 2007-06 PHASE2
NCT00198562 UNKNOWN
Hypertension
Ministry of Health, Labour and Welfare, Japan
 2000-04 PHASE4
NCT01030458 COMPLETED
Blood Pressure
KU Leuven
 2010-09 PHASE4
NCT00498433 TERMINATED
Hypertension; Abdominal Obesity
Novartis
 2007-06 PHASE2
NCT00198562 UNKNOWN
Hypertension
Ministry of Health, Labour and Welfare, Japan
 2000-04 PHASE4
NCT01368536 TERMINATED
Hypertension; Stage 2 Hypertension; Diabetes
Novartis Pharmaceuticals
 2011-05 PHASE4
NCT01368536 TERMINATED
Hypertension; Stage 2 Hypertension; Diabetes
Novartis Pharmaceuticals
 2011-05 PHASE4
NCT01237873 COMPLETED
Essential Hypertension
Novartis Pharmaceuticals
 2011-01 PHASE3
NCT01237873 COMPLETED
Essential Hypertension
Novartis Pharmaceuticals
 2011-01 PHASE3
NCT01264692 COMPLETED
Essential Hypertension
Idorsia Pharmaceuticals Ltd.
 2011-02 PHASE2
NCT01264692 COMPLETED
Essential Hypertension
Idorsia Pharmaceuticals Ltd.
 2011-02 PHASE2
NCT01337674 COMPLETED
Hypertension
Merck Sharp & Dohme LLC
 2011-04-01 PHASE1
NCT01337674 COMPLETED
Hypertension
Merck Sharp & Dohme LLC
 2011-04-01 PHASE1
NCT01180205 UNKNOWN
Hypertension
Johannes Gutenberg University Mainz
 2010-08 PHASE4
NCT00834600 COMPLETED
Hypertension
The Louis & Rachel Rudin Foundation
 2005-12
NCT01180205 UNKNOWN
Hypertension
Johannes Gutenberg University Mainz
 2010-08 PHASE4
NCT00834600 COMPLETED
Hypertension
The Louis & Rachel Rudin Foundation
 2005-12
NCT02292069 COMPLETED
Healthy
Dr. Reddy's Laboratories Limited
 2011-09 PHASE1
NCT01286558 COMPLETED
Hypertension
Boehringer Ingelheim
 2011-01 PHASE3
NCT02292069 COMPLETED
Healthy
Dr. Reddy's Laboratories Limited
 2011-09 PHASE1
NCT01286558 COMPLETED
Hypertension
Boehringer Ingelheim
 2011-01 PHASE3
NCT00454662 COMPLETED
Hypertension; Cardiovascular Disease; Diabetes
COLM Study Research Organization
 2007-04 PHASE4
NCT00454662 COMPLETED
Hypertension; Cardiovascular Disease; Diabetes
COLM Study Research Organization
 2007-04 PHASE4
NCT00818779 COMPLETED
Coronary Artery Disease; Type 2 Diabetes Mellitus
Texas Tech University Health Sciences Center
 2008-01 PHASE4
NCT01341392 COMPLETED
Type 2 Diabetes Mellitus
Chong Kun Dang Pharmaceutical
 2011-04 PHASE1
NCT01103960 COMPLETED
Hypertension
Boehringer Ingelheim
 2010-07 PHASE3
NCT01341392 COMPLETED
Type 2 Diabetes Mellitus
Chong Kun Dang Pharmaceutical
 2011-04 PHASE1
NCT01103960 COMPLETED
Hypertension
Boehringer Ingelheim
 2010-07 PHASE3
NCT00818779 COMPLETED
Coronary Artery Disease; Type 2 Diabetes Mellitus
Texas Tech University Health Sciences Center
 2008-01 PHASE4
NCT01125254 COMPLETED
Thalassemia Major
University of Campinas, Brazil
 2008-09 PHASE2; PHASE3
NCT01204398 COMPLETED
Hypertension
Boehringer Ingelheim
 2010-11 PHASE3
NCT01125254 COMPLETED
Thalassemia Major
University of Campinas, Brazil
 2008-09 PHASE2; PHASE3
NCT01204398 COMPLETED
Hypertension
Boehringer Ingelheim
 2010-11 PHASE3
NCT00902304 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2009-07 PHASE4
NCT00902304 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2009-07 PHASE4
NCT01344629 COMPLETED
Healthy
Boehringer Ingelheim
 2011-04 PHASE1
NCT01344629 COMPLETED
Healthy
Boehringer Ingelheim
 2011-04 PHASE1
NCT01271374 UNKNOWN
Hypertension
InVasc Therapeutics, Inc.
 2010-04 PHASE4
NCT01271374 UNKNOWN
Hypertension
InVasc Therapeutics, Inc.
 2010-04 PHASE4
NCT02962336 COMPLETED
Healthy Subjects
Torrent Pharmaceuticals Limited
 2011-05 PHASE1
NCT01222520 COMPLETED
Hypertension
Boehringer Ingelheim
 2010-10 PHASE3
NCT02962336 COMPLETED
Healthy Subjects
Torrent Pharmaceuticals Limited
 2011-05 PHASE1
NCT01222520 COMPLETED
Hypertension
Boehringer Ingelheim
 2010-10 PHASE3
NCT01830517 COMPLETED
Hypertension; Stroke
Hanmi Pharmaceutical Company Limited
 2007-08 PHASE4
NCT01830517 COMPLETED
Hypertension; Stroke
Hanmi Pharmaceutical Company Limited
 2007-08 PHASE4
NCT01237223 COMPLETED
Essential Hypertension
Novartis
 2010-10 PHASE3
NCT01237223 COMPLETED
Essential Hypertension
Novartis
 2010-10 PHASE3
NCT01280266 COMPLETED
Raynaud Phenomenon
Seoul National University Hospital
 2011-01 PHASE2; PHASE3
NCT01134393 COMPLETED
Hypertension
Boehringer Ingelheim
 2010-05 PHASE3
NCT01280266 COMPLETED
Raynaud Phenomenon
Seoul National University Hospital
 2011-01 PHASE2; PHASE3
NCT01134393 COMPLETED
Hypertension
Boehringer Ingelheim
 2010-05 PHASE3
NCT01352689 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2011-04 PHASE1
NCT01352689 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2011-04 PHASE1
NCT01203696 COMPLETED
Ischemic Heart Disease
Ruttonjee Hospital
 2010-07 PHASE4
NCT01203696 COMPLETED
Ischemic Heart Disease
Ruttonjee Hospital
 2010-07 PHASE4
NCT00891267 COMPLETED
Metabolic Syndrome; Hypertension
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
 2008-10 PHASE3
NCT00891267 COMPLETED
Metabolic Syndrome; Hypertension
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
 2008-10 PHASE3
NCT01131546 COMPLETED
Essential Hypertension
Jiangsu Simcere Pharmaceutical Co., Ltd.
 2009-12 PHASE4
NCT01340131 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2011-01 PHASE1
NCT01131546 COMPLETED
Essential Hypertension
Jiangsu Simcere Pharmaceutical Co., Ltd.
 2009-12 PHASE4
NCT02519010 COMPLETED
Healthy
Genuine Research Center, Egypt
 2011-03 PHASE1
NCT01340131 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2011-01 PHASE1
NCT02519010 COMPLETED
Healthy
Genuine Research Center, Egypt
 2011-03 PHASE1
NCT01128322 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2010-07 PHASE2
NCT01128322 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2010-07 PHASE2
NCT01198249 COMPLETED
Essential Hypertension
Yonsei University
 2010-09 PHASE1
NCT01278797 COMPLETED
Hypertension
Boehringer Ingelheim
 2011-01 PHASE1
NCT01278797 COMPLETED
Hypertension
Boehringer Ingelheim
 2011-01 PHASE1
NCT01198249 COMPLETED
Essential Hypertension
Yonsei University
 2010-09 PHASE1
NCT00923091 COMPLETED
Essential Hypertension
Daiichi Sankyo
 2009-06 PHASE3
NCT00923091 COMPLETED
Essential Hypertension
Daiichi Sankyo
 2009-06 PHASE3
NCT01241487 COMPLETED
Primary Hypertension
Novartis
 2009-02 PHASE4
NCT01241487 COMPLETED
Primary Hypertension
Novartis
 2009-02 PHASE4
NCT01246193 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2010-11 PHASE1
NCT01246193 COMPLETED
Hypertension
Chong Kun Dang Pharmaceutical
 2010-11 PHASE1
NCT01197014 COMPLETED
Healthy
Hanmi Pharmaceutical Company Limited
 2010-09 PHASE1
NCT01181011 COMPLETED
Healthy
Boehringer Ingelheim
 2010-08 PHASE1
NCT01197014 COMPLETED
Healthy
Hanmi Pharmaceutical Company Limited
 2010-09 PHASE1
NCT01181011 COMPLETED
Healthy
Boehringer Ingelheim
 2010-08 PHASE1
NCT00797862 COMPLETED
Hypertension
Novartis
 2008-11 PHASE3
NCT01080768 TERMINATED
Hypertension; Ankle Edema
Novartis Pharmaceuticals
 2010-02 PHASE2
NCT00797862 COMPLETED
Hypertension
Novartis
 2008-11 PHASE3
NCT01080768 TERMINATED
Hypertension; Ankle Edema
Novartis Pharmaceuticals
 2010-02 PHASE2
NCT01113047 COMPLETED
Essential Hypertension
Novartis
 2010-05 PHASE3
NCT01197001 COMPLETED
Healthy
Hanmi Pharmaceutical Company Limited
 2010-08 PHASE1
NCT01070030 COMPLETED
Stage II Hypertension
Novartis
 2010-01 PHASE4
NCT01070030 COMPLETED
Stage II Hypertension
Novartis
 2010-01 PHASE4
NCT01113047 COMPLETED
Essential Hypertension
Novartis
 2010-05 PHASE3
NCT01197001 COMPLETED
Healthy
Hanmi Pharmaceutical Company Limited
 2010-08 PHASE1
NCT00957554 COMPLETED
Hypertension
Sanofi
 2009-07 PHASE3
NCT00957554 COMPLETED
Hypertension
Sanofi
 2009-07 PHASE3
NCT00902538 COMPLETED
Essential Hypertension
Daiichi Sankyo
 2009-04 PHASE3
NCT00902538 COMPLETED
Essential Hypertension
Daiichi Sankyo
 2009-04 PHASE3
NCT00956644 COMPLETED
Hypertension
Sanofi
 2009-07 PHASE3
NCT00956644 COMPLETED
Hypertension
Sanofi
 2009-07 PHASE3
NCT00129233 COMPLETED
Hypertension; Type 2 Diabetes Mellitus
Nagoya University
 2004-10 PHASE4
NCT00129233 COMPLETED
Hypertension; Type 2 Diabetes Mellitus
Nagoya University
 2004-10 PHASE4
NCT00417170 COMPLETED
High Blood Pressure; Metabolic Syndrome; Insulin Resistance; Endothelial Dysfunction
Novartis Pharmaceuticals
 2007-10 PHASE2
NCT00417170 COMPLETED
High Blood Pressure; Metabolic Syndrome; Insulin Resistance; Endothelial Dysfunction
Novartis Pharmaceuticals
 2007-10 PHASE2
NCT01375322 COMPLETED
Hypertension; Diabetes Mellitus, Type 2; Albuminuria
TSH Biopharm Corporation Limited
 2007-06 PHASE4
NCT01375322 COMPLETED
Hypertension; Diabetes Mellitus, Type 2; Albuminuria
TSH Biopharm Corporation Limited
 2007-06 PHASE4
NCT01138826 COMPLETED
Healthy Volunteers
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2010-05 PHASE1
NCT01138826 COMPLETED
Healthy Volunteers
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2010-05 PHASE1
NCT00637078 COMPLETED
Hypertension; Hypercholesterolemia
University of Western Ontario, Canada
 2008-02 PHASE4
NCT00637078 COMPLETED
Hypertension; Hypercholesterolemia
University of Western Ontario, Canada
 2008-02 PHASE4
NCT00134160 COMPLETED
Hypertension; Cardiovascular Diseases
OSCAR Study
 2005-08 PHASE4
NCT00134160 COMPLETED
Hypertension; Cardiovascular Diseases
OSCAR Study
 2005-08 PHASE4
NCT01001572 COMPLETED
Essential Hypertension
Novartis
 2009-09 PHASE3
NCT01001572 COMPLETED
Essential Hypertension
Novartis
 2009-09 PHASE3
NCT00877929 COMPLETED
Hypertension
Boehringer Ingelheim
 2009-02 PHASE3
NCT01117038 COMPLETED
Erectile Dysfunction
VIVUS LLC
 2010-04 PHASE1
NCT00877929 COMPLETED
Hypertension
Boehringer Ingelheim
 2009-02 PHASE3
NCT01117038 COMPLETED
Erectile Dysfunction
VIVUS LLC
 2010-04 PHASE1
NCT01127217 COMPLETED
Hypertension
Hanmi Pharmaceutical Company Limited
 2009-05 PHASE3
NCT01127217 COMPLETED
Hypertension
Hanmi Pharmaceutical Company Limited
 2009-05 PHASE3
NCT00446563 COMPLETED
Hypertension; Hypertrophy, Left Ventricular
Novartis
 2007-03 PHASE3
NCT00446563 COMPLETED
Hypertension; Hypertrophy, Left Ventricular
Novartis
 2007-03 PHASE3
NCT00942994 COMPLETED
Hypertension
Novartis
 2009-06 PHASE4
NCT00942994 COMPLETED
Hypertension
Novartis
 2009-06 PHASE4
NCT00950066 COMPLETED
Hypertension
Sanofi
 2009-07 PHASE2
NCT00950066 COMPLETED
Hypertension
Sanofi
 2009-07 PHASE2
NCT00931710 COMPLETED
Stage 2 Systolic Hypertension
Novartis
 2009-07 PHASE4
NCT00931710 COMPLETED
Stage 2 Systolic Hypertension
Novartis
 2009-07 PHASE4
NCT00787605 COMPLETED
Hypertension; Diabetes Mellitus
Novartis
 2008-11 PHASE4
NCT00787605 COMPLETED
Hypertension; Diabetes Mellitus
Novartis
 2008-11 PHASE4
NCT01004614 COMPLETED
Healthy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2009-11 PHASE1
NCT01004614 COMPLETED
Healthy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2009-11 PHASE1
NCT00860262 COMPLETED
Hypertension
Boehringer Ingelheim
 2009-03 PHASE3
NCT00860262 COMPLETED
Hypertension
Boehringer Ingelheim
 2009-03 PHASE3
NCT00667719 COMPLETED
Essential Hypertension
Novartis
 2008-06-05 PHASE3
NCT00667719 COMPLETED
Essential Hypertension
Novartis
 2008-06-05 PHASE3
NCT00618774 COMPLETED
Hypertension
Boehringer Ingelheim
 2008-01 PHASE3
NCT00407537 COMPLETED
Hypertension; Hypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2007-03 PHASE4
NCT00618774 COMPLETED
Hypertension
Boehringer Ingelheim
 2008-01 PHASE3
NCT00407537 COMPLETED
Hypertension; Hypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2007-03 PHASE4
NCT00867490 COMPLETED
Hypertension
Novartis
 2009-03 PHASE3
NCT00661895 COMPLETED
Hypertension
Creighton University
 2005-08 PHASE4
NCT00867490 COMPLETED
Hypertension
Novartis
 2009-03 PHASE3
NCT00661895 COMPLETED
Hypertension
Creighton University
 2005-08 PHASE4
NCT00765674 COMPLETED
Hypertension
Novartis
 2008-09 PHASE3
NCT00765947 COMPLETED
Essential Hypertension ( Mild to Moderate)
Novartis
 2008-09 PHASE4
NCT00224549 COMPLETED
Hypertension
Assistance Publique - Hôpitaux de Paris
 2005-04 PHASE4
NCT00765674 COMPLETED
Hypertension
Novartis
 2008-09 PHASE3
NCT00765947 COMPLETED
Essential Hypertension ( Mild to Moderate)
Novartis
 2008-09 PHASE4
NCT00224549 COMPLETED
Hypertension
Assistance Publique - Hôpitaux de Paris
 2005-04 PHASE4
NCT00791258 COMPLETED
Hypertension
Daiichi Sankyo
 2008-11 PHASE4
NCT00938197 COMPLETED
Essential Hypertension
Boryung Pharmaceutical Co., Ltd
 2009-06 PHASE1
NCT00791258 COMPLETED
Hypertension
Daiichi Sankyo
 2008-11 PHASE4
NCT00938197 COMPLETED
Essential Hypertension
Boryung Pharmaceutical Co., Ltd
 2009-06 PHASE1
NCT00542269 TERMINATED
Hypertension With Metabolic Syndrome
Novartis
 2008-03 PHASE4
NCT00542269 TERMINATED
Hypertension With Metabolic Syndrome
Novartis
 2008-03 PHASE4
NCT00778921 COMPLETED
Hypertension
Novartis
 2008-10 PHASE3
NCT00624052 COMPLETED
Hypertension
Boehringer Ingelheim
 2008-03 PHASE3
NCT00624052 COMPLETED
Hypertension
Boehringer Ingelheim
 2008-03 PHASE3
NCT00538486 COMPLETED
Hypertension; Obesity
Third Military Medical University
 2008-02 PHASE4
NCT00538486 COMPLETED
Hypertension; Obesity
Third Military Medical University
 2008-02 PHASE4
NCT00754429 COMPLETED
Ischemic Stroke
Taipei Veterans General Hospital, Taiwan
 2004-06 PHASE4
NCT00754429 COMPLETED
Ischemic Stroke
Taipei Veterans General Hospital, Taiwan
 2004-06 PHASE4
NCT00778921 COMPLETED
Hypertension
Novartis
 2008-10 PHASE3
NCT00777946 COMPLETED
Hypertension
Novartis
 2008-10 PHASE3
NCT00777946 COMPLETED
Hypertension
Novartis
 2008-10 PHASE3
NCT00626743 COMPLETED
Hypertension
SK Chemicals Co., Ltd.
 2008-05 PHASE1
NCT01738945 COMPLETED
We Searched for the Effects of Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria.
Gulhane School of Medicine
 2008-02 PHASE4
NCT00626743 COMPLETED
Hypertension
SK Chemicals Co., Ltd.
 2008-05 PHASE1
NCT00294567 COMPLETED
Hypertension; Coronary Atherosclerosis
Juntendo University
 2005-12 PHASE4
NCT01738945 COMPLETED
We Searched for the Effects of Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria.
Gulhane School of Medicine
 2008-02 PHASE4
NCT00492128 COMPLETED
Hypertension
Yokohama City University Medical Center
 2007-09 PHASE4
NCT00294567 COMPLETED
Hypertension; Coronary Atherosclerosis
Juntendo University
 2005-12 PHASE4
NCT00921570 COMPLETED
Diabetes; Hypertension; Proteinuria
Gulhane School of Medicine
 2008-02 PHASE4
NCT00492128 COMPLETED
Hypertension
Yokohama City University Medical Center
 2007-09 PHASE4
NCT00699192 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2008-05 PHASE3
NCT00921570 COMPLETED
Diabetes; Hypertension; Proteinuria
Gulhane School of Medicine
 2008-02 PHASE4
NCT00699192 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2008-05 PHASE3
NCT00649389 COMPLETED
Hypertension
Daiichi Sankyo
 2008-05 PHASE3
NCT00015457 COMPLETED
Focal Dystonia
National Institute of Neurological Disorders and Stroke (NINDS)
 2001-04 PHASE2
NCT00015457 COMPLETED
Focal Dystonia
National Institute of Neurological Disorders and Stroke (NINDS)
 2001-04 PHASE2
NCT00654745 COMPLETED
Type 2 Diabetes; Hypertension
Daiichi Sankyo
 2008-05 PHASE4
NCT00654745 COMPLETED
Type 2 Diabetes; Hypertension
Daiichi Sankyo
 2008-05 PHASE4
NCT00649389 COMPLETED
Hypertension
Daiichi Sankyo
 2008-05 PHASE3
NCT03912285 COMPLETED
Healthy
Korea University Anam Hospital
 2008-01-10 PHASE1
NCT03912285 COMPLETED
Healthy
Korea University Anam Hospital
 2008-01-10 PHASE1
NCT00739596 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2008-07 PHASE4
NCT00591266 COMPLETED
Hypertension
Takeda
 2007-10 PHASE3
NCT00591266 COMPLETED
Hypertension
Takeda
 2007-10 PHASE3
NCT00614380 COMPLETED
Hypertension
Boehringer Ingelheim
 2008-01 PHASE3
NCT00614380 COMPLETED
Hypertension
Boehringer Ingelheim
 2008-01 PHASE3
NCT00739596 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2008-07 PHASE4
NCT00716950 UNKNOWN
Essential Hypertension
University of Pavia
 2008-07 PHASE4
NCT02261064 COMPLETED
Healthy
Boehringer Ingelheim
 2008-12 PHASE1
NCT00716950 UNKNOWN
Essential Hypertension
University of Pavia
 2008-07 PHASE4
NCT02261064 COMPLETED
Healthy
Boehringer Ingelheim
 2008-12 PHASE1
NCT00813722 UNKNOWN
Blood Pressure
University of Sao Paulo
 1999-03 PHASE4
NCT00813722 UNKNOWN
Blood Pressure
University of Sao Paulo
 1999-03 PHASE4
NCT00666536 COMPLETED
Hypertension
Novartis
 2008-03 PHASE4
NCT00666536 COMPLETED
Hypertension
Novartis
 2008-03 PHASE4
NCT00847262 COMPLETED
Hypertension; Obesity; Diabetes
Third Military Medical University
 2008-06 PHASE4
NCT00627952 COMPLETED
Hypertension
University of Erlangen-Nürnberg Medical School
 2007-11 PHASE3
NCT00847262 COMPLETED
Hypertension; Obesity; Diabetes
Third Military Medical University
 2008-06 PHASE4
NCT00627952 COMPLETED
Hypertension
University of Erlangen-Nürnberg Medical School
 2007-11 PHASE3
NCT00940667 COMPLETED
Hypertension
Hanmi Pharmaceutical Company Limited
 2008-05 PHASE3
NCT00940667 COMPLETED
Hypertension
Hanmi Pharmaceutical Company Limited
 2008-05 PHASE3
NCT00940680 COMPLETED
Hypertension
Hanmi Pharmaceutical Company Limited
 2008-04 PHASE3
NCT00940680 COMPLETED
Hypertension
Hanmi Pharmaceutical Company Limited
 2008-04 PHASE3
NCT00446524 COMPLETED
Hypertension
Novartis
 2007-02 PHASE3
NCT00446524 COMPLETED
Hypertension
Novartis
 2007-02 PHASE3
NCT00568178 COMPLETED
Proteinuria
Organon and Co
 2007-06-01 PHASE3
NCT00568178 COMPLETED
Proteinuria
Organon and Co
 2007-06-01 PHASE3
NCT00558428 COMPLETED
Hypertension
Boehringer Ingelheim
 2007-10 PHASE3
NCT00558428 COMPLETED
Hypertension
Boehringer Ingelheim
 2007-10 PHASE3
NCT00558064 COMPLETED
Hypertension
Boehringer Ingelheim
 2007-10 PHASE3
NCT00558064 COMPLETED
Hypertension
Boehringer Ingelheim
 2007-10 PHASE3
NCT00700271 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2007-10 PHASE4
NCT00700271 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2007-10 PHASE4
NCT00550953 COMPLETED
Hypertension
Boehringer Ingelheim
 2007-10 PHASE3
NCT00550953 COMPLETED
Hypertension
Boehringer Ingelheim
 2007-10 PHASE3
NCT00443456 COMPLETED
Hypertension
Pfizer
 2007-05 PHASE3
NCT00443456 COMPLETED
Hypertension
Pfizer
 2007-05 PHASE3
NCT00530946 COMPLETED
Hypertension; Hypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2007-09 PHASE3
NCT00669435 UNKNOWN
Hypertension
University of Pavia
 2008-04 PHASE4
NCT00659451 UNKNOWN
Essential Hypertension; Diabetes Mellitus
University of Pavia
 2008-04 PHASE3
NCT00659451 UNKNOWN
Essential Hypertension; Diabetes Mellitus
University of Pavia
 2008-04 PHASE3
NCT00311155 COMPLETED
Essential Hypertension
Sankyo Pharma Gmbh
 2006-03 PHASE4
NCT00311155 COMPLETED
Essential Hypertension
Sankyo Pharma Gmbh
 2006-03 PHASE4
NCT00412113 COMPLETED
Dyslipidemia; Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2007-01 PHASE4
NCT00530946 COMPLETED
Hypertension; Hypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2007-09 PHASE3
NCT00412113 COMPLETED
Dyslipidemia; Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2007-01 PHASE4
NCT00669435 UNKNOWN
Hypertension
University of Pavia
 2008-04 PHASE4
NCT00425373 COMPLETED
Essential Hypertension
Novartis Pharmaceuticals
 2006-11 PHASE2; PHASE3
NCT00142584 COMPLETED
Hypertension
Mylan Bertek Pharmaceuticals
 2005-08 PHASE3
NCT00425373 COMPLETED
Essential Hypertension
Novartis Pharmaceuticals
 2006-11 PHASE2; PHASE3
NCT00142584 COMPLETED
Hypertension
Mylan Bertek Pharmaceuticals
 2005-08 PHASE3
NCT00368277 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2006-09 PHASE3
NCT00368277 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2006-09 PHASE3
NCT00170950 TERMINATED
Hypertension
Novartis
 2003-10 PHASE3
NCT00170950 TERMINATED
Hypertension
Novartis
 2003-10 PHASE3
NCT00523549 COMPLETED
Hypertension; Diastolic Dysfunction
Novartis Pharmaceuticals
 2006-11 PHASE4
NCT00523549 COMPLETED
Hypertension; Diastolic Dysfunction
Novartis Pharmaceuticals
 2006-11 PHASE4
NCT00942344 COMPLETED
Hypertension
Hanmi Pharmaceutical Company Limited
 2007-05 PHASE2
NCT00523744 COMPLETED
Hypertension
Novartis
 2007-07 PHASE3
NCT00942344 COMPLETED
Hypertension
Hanmi Pharmaceutical Company Limited
 2007-05 PHASE2
NCT00523744 COMPLETED
Hypertension
Novartis
 2007-07 PHASE3
NCT00400777 COMPLETED
Hypertension
Novartis
 2006-08 PHASE4
NCT00439738 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2006-12 PHASE4
NCT00400777 COMPLETED
Hypertension
Novartis
 2006-08 PHASE4
NCT00439738 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2006-12 PHASE4
NCT00437645 COMPLETED
Essential Hypertension
Novartis Pharmaceuticals
 2007-01 PHASE3
NCT02259803 COMPLETED
Healthy
Boehringer Ingelheim
 2007-10 PHASE1
NCT00437645 COMPLETED
Essential Hypertension
Novartis Pharmaceuticals
 2007-01 PHASE3
NCT02259803 COMPLETED
Healthy
Boehringer Ingelheim
 2007-10 PHASE1
NCT00413413 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2007-01 PHASE3
NCT00413049 COMPLETED
Hypertension
Novartis
 2007-01 PHASE3
NCT00413413 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2007-01 PHASE3
NCT00413049 COMPLETED
Hypertension
Novartis
 2007-01 PHASE3
NCT02259829 COMPLETED
Healthy
Boehringer Ingelheim
 2007-09 PHASE1
NCT02259777 COMPLETED
Healthy
Boehringer Ingelheim
 2007-09 PHASE1
NCT02259829 COMPLETED
Healthy
Boehringer Ingelheim
 2007-09 PHASE1
NCT02259777 COMPLETED
Healthy
Boehringer Ingelheim
 2007-09 PHASE1
NCT00171054 COMPLETED
Hypertension
Novartis
 2003-09 PHASE4
NCT00171054 COMPLETED
Hypertension
Novartis
 2003-09 PHASE4
NCT00415623 COMPLETED
Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2007-01 PHASE3
NCT00425997 COMPLETED
Hypertension
Novartis
 2006-12 PHASE4
NCT00415623 COMPLETED
Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2007-01 PHASE3
NCT00425997 COMPLETED
Hypertension
Novartis
 2006-12 PHASE4
NCT00338338 COMPLETED
Uncomplicated Hypertension; Hypertension; Essential
GlaxoSmithKline
 2005-11-07 PHASE4
NCT00338338 COMPLETED
Uncomplicated Hypertension; Hypertension; Essential
GlaxoSmithKline
 2005-11-07 PHASE4
NCT00327587 COMPLETED
Hypertension
Novartis
 2006-05 PHASE3
NCT02259790 COMPLETED
Healthy
Boehringer Ingelheim
 2007-07 PHASE1
NCT00327587 COMPLETED
Hypertension
Novartis
 2006-05 PHASE3
NCT02259790 COMPLETED
Healthy
Boehringer Ingelheim
 2007-07 PHASE1
NCT01505998 COMPLETED
Fed
Dr. Reddy's Laboratories Limited
 2007-03 PHASE1
NCT01505998 COMPLETED
Fed
Dr. Reddy's Laboratories Limited
 2007-03 PHASE1
NCT00350168 COMPLETED
Hypertension
Novartis
 2006-06 PHASE3
NCT01506011 COMPLETED
Fasting
Dr. Reddy's Laboratories Limited
 2007-03 PHASE1
NCT00353912 COMPLETED
Hypertension
Novartis
 2006-06 PHASE3
NCT00350168 COMPLETED
Hypertension
Novartis
 2006-06 PHASE3
NCT01506011 COMPLETED
Fasting
Dr. Reddy's Laboratories Limited
 2007-03 PHASE1
NCT00353912 COMPLETED
Hypertension
Novartis
 2006-06 PHASE3
NCT00313547 TERMINATED
Hypertension
Montreal Heart Institute
 2006-04 PHASE4
NCT00313547 TERMINATED
Hypertension
Montreal Heart Institute
 2006-04 PHASE4
NCT00242814 COMPLETED
Hypertension; Metabolic Syndrome X
Boehringer Ingelheim
 2005-11-03 PHASE4
NCT00242814 COMPLETED
Hypertension; Metabolic Syndrome X
Boehringer Ingelheim
 2005-11-03 PHASE4
NCT00351130 COMPLETED
Hypertension
Novartis
 2006-06 PHASE4
NCT00351130 COMPLETED
Hypertension
Novartis
 2006-06 PHASE4
NCT00281580 COMPLETED
Hypertension
Boehringer Ingelheim
 2006-04 PHASE3
NCT00281580 COMPLETED
Hypertension
Boehringer Ingelheim
 2006-04 PHASE3
NCT00304226 COMPLETED
Hypertension
Novartis
 2006-02 PHASE4
NCT00304226 COMPLETED
Hypertension
Novartis
 2006-02 PHASE4
NCT00327145 COMPLETED
Hypertension
Novartis
 2006-03 PHASE3
NCT00327145 COMPLETED
Hypertension
Novartis
 2006-03 PHASE3
NCT00360178 COMPLETED
Hypertension
Novartis
 2006-07 PHASE3
NCT00360178 COMPLETED
Hypertension
Novartis
 2006-07 PHASE3
NCT00185120 COMPLETED
Hypertension
Daiichi Sankyo
 2005-09 PHASE4
NCT00185120 COMPLETED
Hypertension
Daiichi Sankyo
 2005-09 PHASE4
NCT02259816 COMPLETED
Healthy
Boehringer Ingelheim
 2006-05 PHASE1
NCT02259816 COMPLETED
Healthy
Boehringer Ingelheim
 2006-05 PHASE1
NCT00294710 COMPLETED
Hypertension
Novartis
 2005-03 PHASE3
NCT00294710 COMPLETED
Hypertension
Novartis
 2005-03 PHASE3
NCT00367939 COMPLETED
Hypertension
Novartis
 2005-12 PHASE3
NCT00367939 COMPLETED
Hypertension
Novartis
 2005-12 PHASE3
NCT00219115 COMPLETED
Hypertension
Novartis
 2005-01 PHASE3
NCT00219115 COMPLETED
Hypertension
Novartis
 2005-01 PHASE3
NCT00157963 COMPLETED
Essential Hypertension
Organon and Co
 2005-02-05 PHASE4
NCT00157963 COMPLETED
Essential Hypertension
Organon and Co
 2005-02-05 PHASE4
NCT00219154 COMPLETED
Hypertension
Novartis
 2005-03 PHASE3
NCT00219154 COMPLETED
Hypertension
Novartis
 2005-03 PHASE3
NCT00136773 COMPLETED
Albuminuria
Novartis
 2003-04 PHASE4
NCT00136773 COMPLETED
Albuminuria
Novartis
 2003-04 PHASE4
NCT00775151 COMPLETED
Healthy
Ranbaxy Laboratories Limited
 2005-07
NCT00775151 COMPLETED
Healthy
Ranbaxy Laboratories Limited
 2005-07
NCT00775905 COMPLETED
Healthy
Ranbaxy Laboratories Limited
 2005-07
NCT00775905 COMPLETED
Healthy
Ranbaxy Laboratories Limited
 2005-07
NCT00136851 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2004-12 PHASE4
NCT00136851 COMPLETED
Hypertension
Novartis Pharmaceuticals
 2004-12 PHASE4
NCT00772499 COMPLETED
Hypertension
Daiichi Sankyo
 2002-11 PHASE4
NCT00772499 COMPLETED
Hypertension
Daiichi Sankyo
 2002-11 PHASE4
NCT00171002 COMPLETED
Hypertension
Novartis
 2004-11 PHASE3
NCT00171002 COMPLETED
Hypertension
Novartis
 2004-11 PHASE3
NCT00170976 COMPLETED
HYPERTENSION
Novartis
 2004-04 PHASE3
NCT00170976 COMPLETED
HYPERTENSION
Novartis
 2004-04 PHASE3
NCT00870571 COMPLETED
Healthy
Actavis Inc.
 2005-04 PHASE1
NCT00870142 COMPLETED
Healthy
Actavis Inc.
 2005-04 PHASE1
NCT00870142 COMPLETED
Healthy
Actavis Inc.
 2005-04 PHASE1
NCT00870571 COMPLETED
Healthy
Actavis Inc.
 2005-04 PHASE1
NCT00171535 COMPLETED
Hypertension
Novartis
 2004-10 PHASE3
NCT01518855 COMPLETED
Hypertension
Bayer
 2004-03 PHASE4
NCT01518855 COMPLETED
Hypertension
Bayer
 2004-03 PHASE4
NCT00171535 COMPLETED
Hypertension
Novartis
 2004-10 PHASE3
NCT00409851 COMPLETED
Hypertension
Novartis
 2003-04 PHASE3
NCT00234871 COMPLETED
Hypertension; Diabetes; Proteinuria
Abbott
 2004-01 PHASE4
NCT00409851 COMPLETED
Hypertension
Novartis
 2003-04 PHASE3
NCT00234871 COMPLETED
Hypertension; Diabetes; Proteinuria
Abbott
 2004-01 PHASE4
NCT00091429 COMPLETED
Angina
Gilead Sciences
 2004-08 PHASE3
NCT00091429 COMPLETED
Angina
Gilead Sciences
 2004-08 PHASE3
NCT00409643 COMPLETED
Hypertension
Novartis
 2004-01 PHASE3
NCT00409643 COMPLETED
Hypertension
Novartis
 2004-01 PHASE3
NCT00140959 COMPLETED
Hypertension
Organon and Co
 2003-02-01 PHASE4
NCT00140959 COMPLETED
Hypertension
Organon and Co
 2003-02-01 PHASE4
NCT00649402 COMPLETED
Healhty
Mylan Pharmaceuticals Inc
 2004-05 PHASE1
NCT00649402 COMPLETED
Healhty
Mylan Pharmaceuticals Inc
 2004-05 PHASE1
NCT00649519 COMPLETED
Healthy
Mylan Pharmaceuticals Inc
 2004-05 PHASE1
NCT00834977 COMPLETED
Healthy
Teva Pharmaceuticals USA
 2004-04 PHASE1
NCT00602017 COMPLETED
Hypertension; Chronic Stable Angina; Vasospastic Angina
Roxane Laboratories
 2004-04
NCT00834977 COMPLETED
Healthy
Teva Pharmaceuticals USA
 2004-04 PHASE1
NCT00649519 COMPLETED
Healthy
Mylan Pharmaceuticals Inc
 2004-05 PHASE1
NCT00602017 COMPLETED
Hypertension; Chronic Stable Angina; Vasospastic Angina
Roxane Laboratories
 2004-04
NCT03276598 COMPLETED
Hypertension; Pharmacogenetics
Helsinki University Central Hospital
 1999-11-25 PHASE4
NCT03276598 COMPLETED
Hypertension; Pharmacogenetics
Helsinki University Central Hospital
 1999-11-25 PHASE4
NCT00601302 COMPLETED
Hypertension; Chronic Stable Angina; Vasospastic Angina
Roxane Laboratories
 2004-04
NCT00601302 COMPLETED
Hypertension; Chronic Stable Angina; Vasospastic Angina
Roxane Laboratories
 2004-04
NCT00240474 COMPLETED
Hypertension
Boehringer Ingelheim
 2002-12 PHASE4
NCT00240474 COMPLETED
Hypertension
Boehringer Ingelheim
 2002-12 PHASE4
NCT01155895 COMPLETED
Healthy
Dr. Reddy's Laboratories Limited
 2004-03 PHASE1
NCT01155895 COMPLETED
Healthy
Dr. Reddy's Laboratories Limited
 2004-03 PHASE1
NCT00835367 COMPLETED
Healthy
Teva Pharmaceuticals USA
 2004-03 PHASE1
NCT00835367 COMPLETED
Healthy
Teva Pharmaceuticals USA
 2004-03 PHASE1
NCT06395194 COMPLETED
Essential Hypertension
Oslo University Hospital
 1997-09-27 PHASE3
NCT06395194 COMPLETED
Essential Hypertension
Oslo University Hospital
 1997-09-27 PHASE3
NCT00367978 COMPLETED
Hypertension
Novartis
 2001-12 PHASE4
NCT00367978 COMPLETED
Hypertension
Novartis
 2001-12 PHASE4
NCT00841815 COMPLETED
Healthy
Teva Pharmaceuticals USA
 2003-04 PHASE1
NCT00841815 COMPLETED
Healthy
Teva Pharmaceuticals USA
 2003-04 PHASE1
NCT01131923 COMPLETED
Healthy
Dr. Reddy's Laboratories Limited
 2002-10 PHASE1
NCT01131923 COMPLETED
Healthy
Dr. Reddy's Laboratories Limited
 2002-10 PHASE1
NCT01131936 COMPLETED
Healthy
Dr. Reddy's Laboratories Limited
 2002-08 PHASE1
NCT01131936 COMPLETED
Healthy
Dr. Reddy's Laboratories Limited
 2002-08 PHASE1
NCT00000542 COMPLETED
Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Heart Diseases; Hypercholesterolemia; Hypertension; Myocardial Infarction; Myocardial Ischemia; Heart Failure
National Heart, Lung, and Blood Institute (NHLBI)
 1993-08 PHASE3
NCT00000542 COMPLETED
Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Heart Diseases; Hypercholesterolemia; Hypertension; Myocardial Infarction; Myocardial Ischemia; Heart Failure
National Heart, Lung, and Blood Institute (NHLBI)
 1993-08 PHASE3
NCT00140985 COMPLETED
Renal Disorder
Organon and Co
 2000-02 PHASE4
NCT00140985 COMPLETED
Renal Disorder
Organon and Co
 2000-02 PHASE4
NCT04364139 COMPLETED
Hypertensive Nephrosclerosis; Chronic Renal Insufficiency
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
 1995-02-01 PHASE3
NCT04364139 COMPLETED
Hypertensive Nephrosclerosis; Chronic Renal Insufficiency
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
 1995-02-01 PHASE3
NCT00151619 TERMINATED
Chronic Heart Failure
Rennes University Hospital
 1999-02-10 PHASE2
NCT00151619 TERMINATED
Chronic Heart Failure
Rennes University Hospital
 1999-02-10 PHASE2
NCT02177409 COMPLETED
Hypertension
Boehringer Ingelheim
 1998-04 PHASE3
NCT02177409 COMPLETED
Hypertension
Boehringer Ingelheim
 1998-04 PHASE3
NCT00039975 COMPLETED
HIV Infections; Cardiovascular Diseases; Hypertension
National Institute of Allergy and Infectious Diseases (NIAID)
 PHASE1
NCT00000522 COMPLETED
Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases
University of Minnesota
 1985-08 PHASE2
NCT00382421 COMPLETED
Myocardial Ischemia
Luzerner Kantonsspital
 1992-02
NCT00150384 COMPLETED
Hypertension; Dyslipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2004-07 PHASE4
NCT00289406 COMPLETED
Hypertension
SK Chemicals Co., Ltd.
 2006-01 PHASE3
NCT00819104 COMPLETED
Primary Hypertension
AstraZeneca
 2008-11 PHASE4
NCT00741078 COMPLETED
Hypertension
Gachon University Gil Medical Center
 2004-12 PHASE4
NCT00932763 COMPLETED
Healthy
Torrent Pharmaceuticals Limited
 PHASE1
NCT00159718 COMPLETED
Angina
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2001-07 PHASE4
NCT00741078 COMPLETED
Hypertension
Gachon University Gil Medical Center
 2004-12 PHASE4
NCT00330785 COMPLETED
Hypertension; Dyslipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2004-10 PHASE3
NCT01089452 WITHDRAWN
Hypertension
Monash University
 PHASE4
NCT00932763 COMPLETED
Healthy
Torrent Pharmaceuticals Limited
 PHASE1
NCT00156403 COMPLETED
Pancreatitis
University of Pittsburgh
 2005-08 PHASE1; PHASE2
NCT00159718 COMPLETED
Angina
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2001-07 PHASE4
NCT00160212 COMPLETED
Hypertension
Solvay Pharmaceuticals
 2004-12 PHASE2
NCT00330785 COMPLETED
Hypertension; Dyslipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2004-10 PHASE3
NCT00174330 COMPLETED
Hypertension; Hyperlipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2005-05 PHASE4
NCT01089452 WITHDRAWN
Hypertension
Monash University
 PHASE4
NCT00174304 COMPLETED
Hypertension; Hyperlipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2004-10 PHASE4
NCT00156403 COMPLETED
Pancreatitis
University of Pittsburgh
 2005-08 PHASE1; PHASE2
NCT00160212 COMPLETED
Hypertension
Solvay Pharmaceuticals
 2004-12 PHASE2
NCT00174330 COMPLETED
Hypertension; Hyperlipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2005-05 PHASE4
NCT00202618 UNKNOWN
Hypertension; Diabetes Mellitus; Albuminuria
Shiga University
 2003-12 PHASE4
NCT00174304 COMPLETED
Hypertension; Hyperlipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2004-10 PHASE4
NCT00426478 COMPLETED
Hypertension
Novartis
 2006-11 PHASE4
NCT00202618 UNKNOWN
Hypertension; Diabetes Mellitus; Albuminuria
Shiga University
 2003-12 PHASE4
NCT00159692 COMPLETED
Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2003-03 PHASE4
NCT00426478 COMPLETED
Hypertension
Novartis
 2006-11 PHASE4
NCT00548067 COMPLETED
Hypertension
Novartis
 2007-09 PHASE3
NCT00159692 COMPLETED
Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2003-03 PHASE4
NCT00237588 COMPLETED
Hypertension
Ullevaal University Hospital
 2004-12 PHASE4
NCT00548067 COMPLETED
Hypertension
Novartis
 2007-09 PHASE3
NCT00237588 COMPLETED
Hypertension
Ullevaal University Hospital
 2004-12 PHASE4
NCT00143195 COMPLETED
Myocardial Ischemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2001-04 PHASE4
NCT00932880 COMPLETED
Healthy
Torrent Pharmaceuticals Limited
 PHASE1
NCT00039975 COMPLETED
HIV Infections; Cardiovascular Diseases; Hypertension
National Institute of Allergy and Infectious Diseases (NIAID)
 PHASE1
NCT00000522 COMPLETED
Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases
University of Minnesota
 1985-08 PHASE2
NCT00382421 COMPLETED
Myocardial Ischemia
Luzerner Kantonsspital
 1992-02
NCT00150384 COMPLETED
Hypertension; Dyslipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2004-07 PHASE4
NCT00289406 COMPLETED
Hypertension
SK Chemicals Co., Ltd.
 2006-01 PHASE3
NCT00143195 COMPLETED
Myocardial Ischemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
 2001-04 PHASE4
NCT00932880 COMPLETED
Healthy
Torrent Pharmaceuticals Limited
 PHASE1
NCT00819104 COMPLETED
Primary Hypertension
AstraZeneca
 2008-11 PHASE4

(data from https://clinicaltrials.gov, updated on 2025-12-09)

Check the Amlodipine Besylate product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Compliance for Clinical Use

Mechanism and Biochemical Profile

Amlodipine besylate selectively binds to voltage-gated calcium channels and inhibits transmembrane calcium ion influx into vascular smooth muscle cells, preventing intracellular calcium elevation and excitation-contraction coupling. This cellular inhibition promotes widespread peripheral arterial vasodilation, resulting in reduced vascular resistance and systemic blood pressure reduction in clinical conditions such as hypertension.

Appendix RUO and cGMP Quality Standards

Quality Dimension RUO (Research Use Only) cGMP (Current Good Manufacturing Practice)
Clinical Applicability Prohibited in human clinical trials or medical diagnostics. Mandatory for human clinical trials (Phase I–III) and therapies.
Regulatory Status Non-regulated grade; exempt from drug manufacturing laws. Legally enforced by health authorities (e.g., FDA, EMA, NMPA).
Facility Environment Unclassified analytical or research laboratories. Validated Cleanrooms (ISO Class 5–8) with continuous monitoring.
Quality Control Basic purity and activity testing. Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma).
Process Validation Basic equipment calibration; no process validation required. Full qualification (IQ/OQ/PQ) and complete batch records.
Quality Assurance Vendor self-declared without required formal QMS. Mandatory QA/QC unit, Change Control, CAPA, and vendor audits.
Regulatory Impact High risk of IND rejection if used as a critical raw material. Required for IND/NDA filings, supported by Drug Master Files (DMF).

Footnotes

Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).

Jump to

Note: Technical data last updated: Sep 1, 2026.